ŠĻą”±į>ž’  ž’’’~Ö’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’ģ„Įq`ųæÜ£bjbjqPqP @¼::-š’’’’’’¤nnnnnnn‚ę{ę{ę{8|$B~<‚?Ź.Š€Ųb‚x‚x‚x‚Wƒ wƒ ƒƒ²É“ɓɓɓɓɓÉ$mĢhÕΤŲÉ!n8‰SƒWƒ8‰8‰ŲÉnnx‚x‚ŪłÉ( ( ( 8‰$ nx‚nx‚²É( 8‰²É( ( r®©TnnŠŖx‚~€ F’°ŁøÉę{\–øŖ~³4Ź0?ŹŖzyŠš¼yŠŠŖŠŖĄyŠnJ¬4‹ƒœ'…&( M†ģ9‡’‹ƒ‹ƒ‹ƒŲÉŲÉŠŸX‹ƒ‹ƒ‹ƒ?Ź8‰8‰8‰8‰‚‚‚dmę{‚‚‚ę{‚‚‚nnnnnn’’’’ Serum antibodies positivity to twelve Helicobacter pylori virulence antigens in patients with benign or malignant gastroduodenal diseases – cross-sectional study Authors: Tajana Filipec Kanizaj Miroslava Katicic Vladimir Presecki1 Slavko Gasparov2 Vesna Colic Cvrlje Branko Kolaric3 Anna Mrzljak Department of Internal medicine, University Hospital Merkur, Faculty of Medicine, Zajceva 19, 10 000 Zagreb, Croatia 1Department of Microbiology and Parasitology, Faculty of Medicine, Salata 3b, Zagreb, Croatia 2Department of Pathology, University Hospital Merkur, Faculty of Medicine, Zajceva 19, 10 000 Zagreb, Croatia 3Social medicine and gerontology service, Zagreb County Institute of Public Health, Matice hrvatske bb, 10410 Velika Gorica Running head: Filipec et al. H. pylori Antigens in Gastroduodenal Diseases Abstract Aim: To investigate the association of gastric histological and endoscopic findings in patients with H. pylori, according to presence of seropositivity to 12 bacterial virulence antigens. Methods: The study is a cross – sectional single center analysis of 360 consecutive outpatients referred in a single year to upper gastrointestinal endoscopy because of dyspeptic complaints. Patients sera were tested by Western blot method to determine the presence of serum antibodies to bacterial virulence antigens (p120 (CagA), p95 (VacA), p67 (FSH), p66 (UreB), p57 (HSP homolog), p54 (flagellin), p33, p30 (OMP), p29 (UreA), p26, p19, and p17). Upper gastrointestinal endoscopy was performed, endoscopic diagnosis recorded, and 4 mucosal biopsy samples obtained and assessed according to Updated Sydney protocol. Results: The sera of 207 patients were analyzed. 30 patients had gastric adenocarcinoma, 126 peptic ulcers and 51 normal finding. P120 (CagA) seropositivity was significantly more often present in patients with higher activity grade in the antrum (P=0.025), p30 (OMP) with greater inflammation in the antrum (P=0.025) and the corpus (P=0.010), p33 with greater inflammation in the corpus (P=0.050) and p19 (OMP) with lower intestinal metaplasia grades in the corpus (P=0.025) of the stomach. Seroreactivity to all other bacterial proteins showed no association with the histological status of the stomach mucosa. Except for the seropositivity to protein p95 (VacA), which was more often present in patients with duodenal ulcer (P=0.006), there was no difference in seroreactivity to other bacterial proteins and upper gastrointestinal endoscopic findings. Conclusions: P120 (CagA), p33, p 30 (OMP) and p19 (OMP) seropositivity were more often present in patients with higher grades of the histological parameters of gastritis and seropositivity to protein p95 (VacA) with endoscopic presence of duodenal ulcer. Histological parameters of gastritis are rather associated with bacterial virulence than endoscopic findings. Keywords: H. pylori, gastritis, virulence antigens, CagA, VacA, p 19, p 30, p 33 Introduction Helicobacter pylori (H. pylori) is recognized as a major gastric pathogen with worldwide distribution (1). Estimated prevalence of H. pylori infection in Croatia is 60.4% (2). The persistent colonization induces gastritis and in some patients peptic ulcer disease, atrophic gastritis or gastric carcinoma (3). However, most of patients infected with H. pylori never develop the cancer or ulcer disease and there is need to identify additional factors that may influence the risk for development of such diseases. The outcome of H. pylori infection is associated with specific (virulence associated) bacterial genotypes, environmental factors and host's immune status (4). A number of putative virulence factors for H. pylori infection have been identified including: CagA (cytotoxin - associated antigen), VacA (vacuolating cytotoxin), IceA (induced by epithelium antigen), BabA (blood-group antigen-binding adhesin), etc. It is likely that every other factor that results in increased inflammation will also consequently increase the risk of a disease occurrence. Presently, the only reliable way to identify the disease associated with H. pylori infection remains an endoscopic examination together with histological assessment of the gastric mucosa (5). The bacterial virulence antigens elicit specific antibodies during infection. But, the value of these antibodies as predictive factors for the severity of the disease remains controversial (6-15). To define the correlation so far several investigations were done, such as: detecting the level, the specificity or presence of isotypes of serum H. pylori antibodies (16-22). Because disease outcome depends on both, the strain characteristics and the host response, the serum antibody response to virulence antigens could provide clues in predicting the presence and severity of associated diseases (23, 24). On the other side, the fact that subjects without significant disease also have strains bearing this or other virulence antigens arise suspicion to assign disease to one virulence antigen alone. Thus other virulence antigens may be important. Exact role of other bacterial virulence antigens (p67 (FSH - flagellar sheath protein), p66 (UreB - urease enzyme heavy subunit), p57 (HSP homolog - heath shock protein homolog), p54 (flagellin), p33, p30 (OMP - outer membrane protein), p29 (UreA - urease enzyme light subunit), p26, p19 (OMP), p17) in pathogenesis of gastrointestinal diseases is still unclear. In this study, we aimed to investigate the association of gastric histological and endoscopic findings in H. pylori positive patients according to presence of seropositivity to 12 bacterial virulence antigens. Since both bacterial virulence antigens and pattern of H. pylori gastritis may contribute to development of clinically relevant gastroduodenal disease, we sought to determine the antibodies which are best associated with higher grades of histology findings of gastritis, atrophy or intestinal metaplasia and different clinical diseases (peptic ulcer, gastric cancer, non - ulcer dyspepsia). Methods Patients In year of 2000, 360 consecutive outpatients referred to upper gastrointestinal endoscopy because of dyspeptic complaints were screened. Before entering the study, all patients provided written informed consent. The research protocol was approved by the Clinical Research Ethical Committee of the University Hospital Merkur in Zagreb. All procedures were in accordance with the Declaration of Helsinki revision 2008 (25). 207 patients were eligible for the study. Inclusion criteria for the study were: age older than 18 years, positive to H. pylori (proven by histology and serology) and no data about previous eradication treatment for H. pylori infection. The exclusion criteria were: previous eradication treatment, any antimicrobial treatment 2 months preceding the study, concomitant medication with: bismuth preparations, proton pump inhibitors, H2-receptor antagonists or NASID (non-steroid anti-inflammatory drugs), other serious illnesses, and history of previous gastric surgery. H. pylori positive status was proven by histology and serology (Western blot). At examination upper gastrointestinal endoscopy was performed and 4 gastric mucosa biopsy samples were obtained (2 from antrum and 2 from corpus). Additionally 1 vial of venous blood was obtained for serological examination. According to endoscopic findings patients were divided into five groups as follows: normal mucosa (N), duodenal ulcer (D), gastric ulcer (V), duodenal and gastric ulcer (VD), gastric adenocarcinoma (C). Histology For histological examination 4 biopsy samples were obtained: 2 from antrum and 2 from corpus of gastric mucosa. The biopsy samples were embedded in paraffin wax and stained with haematoxilyn and eosin, modified 2% Giemsa stain and alcian blue - PAS (periodic acid Schiff). All samples were analyzed for H pylori density, activity (intensity of polymorphonuclear cells infiltrates), inflammation (intensity of mononuclear cells infiltrates), atrophy, and intestinal metaplasia, as stipulated by Updated Sydney system classification (26). All parameters were graded as none (0), mild (1), moderate (2), or marked (3). Intestinal metaplasia was recognized morphologically with the presence of goblet cells, absorptive cells, and cells resembling colonocytes. Results from two antrum or corpus biopsy samples were combined and whenever differences were observed, the highest score was considered for statistical analysis. Serology Sera analysis was performed with commercially available Anti – Helicobacter pylori – Western blot test kit (Western blot, Euroimmun Medizinische Labordiagnostika AG, Lubeck). Procedure was performed according to manufacture instructions. Test is based on detection of anti H. pylori antigens IgG antibodies to twelve H. pylori specific and unspecific (cross – reacting or undefined) antigens. Antigen source for this commercially available anti – Helicobacter pylori - Western blot test is provided by the H. pylori type strain (27). Serum samples were assayed for 12 antibodies to H. pylori antigens: p120 (CagA; cytotoxin - associated antigen), p95 (VacA; vacuolating cytotoxin), p67 (FSH; flagellar sheath protein), p66 (UreB; urease enzyme heavy subunit), p57 (HSP homolog; heath shock protein homolog), p54 (flagellin), p33, p30 (OMP; outer membrane protein), p29 (UreA; urease enzyme light subunit), p26, p19 (OMP) and p17 by Western blot method. Proteins p 120 (CagA), p 95 (VacA), p33, p30 (OMP), p29 (UreA), p26, p19 (OMP), p17 are H. pylori strain specific antigens and p67 (FSH), p66 (UreB), p57 (HSP homolog), p54 (flagellin) are cross-reacting or undefined antigens. Statistics The associations between H. pylori individual virulence antigens and presence of mucosal histological changes or clinical disease were analyzed using (2 – test. Odds ratios (ORs) with confidence intervals were assessed by bivariate logistic regression. The t- test was used to analyze the age distribution between the different patients groups. STATISTICA for Windows, Release 5.5 H* and SPSS for Windows Release 17.01 were used in statistical analysis. Results Study population All 207 patients included in the study were H. pylori positive, confirmed by histology and serology (Western blot). Among them 113 were males (mean age 57.96±14.10 SD) and 94 were females (mean age 57.86±14.69 SD) (P= 0.960). In Table 1. demographic, endoscopic diagnosis, serological and patohistological findings of all 207 patients are presented. In corpus mucosa inflammation was present in 91.1 % patients, activity 50.1%, atrophy 7.2%, and intestinal metaplasia 11.1 % respectively. Figure 1. represent distribution of different grades of patohistological parameters of gastritis in corpus of patients with benign and malignant gastroduodenal diseases. Patohistological analysis of the antrum mucosa revealed inflammation in 51.2% patients, activity 74.9%, atrophy 10.6% and intestinal metaplasia 23.2% respectively. Figure 2 represent distribution of different grades of patohistological parameters of gastritis in antrum mucosa of patients with benign and malignant gastroduodenal diseases. Out of 30 patients with gastric adenocarcinoma, 23 had intestinal and 7 diffuse respectively. Of all patients 18 had tumor in antrum and 12 in corpus part of the stomach. Correlation of H. pylori virulence antigens and gastric histology The correlation of histological features and seropositivity status revealed statistically significant results for proteins p120 (CagA), p30 (OMP), p33 and p19 as followed: p120 (CagA) seropositivity was associated with higher activity grades (P=0.025) in antrum, p30 (OMP) seropositivity with higher inflammation grades in both, corpus (P=0.010) and antrum (P=0.025) and antigen p33 higher inflammation grades in corpus (P=0.050). Contrary, seropositivity to p19 (OMP) antigen was associated with presence of lower grades of intestinal metaplasia in corpus (P=0.025) of gastric mucosa. Complete data of histological finding of gastric mucosa according to seropositivity to p 120 (CagA), p19, p30 (OMP) and p33 proteins are provided in Table 2. There was no statistically significant difference in the distribution of histological parameters of gastritis with respect to serological status to other tested bacterial virulence antigens. Correlation of H. pylori virulence antigens and endoscopic diagnosis Seropositivity to antigen p95 (VacA) was statistically significantly more often observed in patients with duodenal ulcer and less in those with normal mucosa and gastric carcinoma (P=0.006). Sensitivity and specificity of positive serology finding to p95 (VacA), in order to detect patients with duodenal ulcer, were 91.18% and 31.65%. Analogously, to gastric carcinoma 60.00% and 21.47%, gastric ulcer 71.74% and 22.98%, simultaneous gastric and duodenal ulcer 66.67% and 23.59%, and normal mucosa finding 70.59% and 22.44% respectively. There was no association between seropositivity to any other of eleven H. pylori virulence proteins and endoscopic finding. The distributions of different endoscopy findings and antibodies to H. pylori virulence antigens are summarized in Table 3. Discussion The results of our study demonstrate the association of seropositivity to p120 (CagA), p33 and p 30 (OMP) with higher grades of the histological parameters of gastritis and seropositivity to p19 (OMP) with lower grades of intestinal metaplasia. Only protein p95 (VacA) seropositivity was strongly associated with endoscopic presence of duodenal ulcer. So far, many attempts have been made before to find serological markers of H. pylori virulence which could be correlated with the severity of the H. pylori-associated diseases. Data from these studies indicate that seropositivity to some H. pylori antigens could be used as serological markers for bacterial virulence (19, 28-33). Comparing serology findings to twelve H. pylori virulence antigens with gastric mucosa histopathological findings we noticed that p120 (CagA) seropositivity was associated with the higher activity grades in antrum, p30 (OMP) seropositivity with higher inflammation grades in both antrum and corpus, p33 seropositivity with higher inflammation grades in corpus and p19 (OMP) seropositivity with lower grades of intestinal metaplasia in corpus of gastric mucosa. Protein CagA is the most investigated H. pylori virulence factor but, its connection with presence of various mucosal histological changes is still controversial and there are many studies with contradictory results (34-37). Our results are consistent with previous observations where CagA elicit high neutrophil accumulation measured as inflammation activity in gastric mucosa (33). According to the results of previously published studies, this can be related to strong stimulation of IL-8 production by CagA positive strains (38, 39). There are no previously published data on association of seropositivity to proteins p30 (OMP), p33 and p19 (OMP) and different patterns of gastritis. First step in all H. pylori related diseases is emergence of gastritis. Possible pathogenetic mechanisms involved in association of these proteins with higher grades of gastritis should be additionally investigated regarding implications in occurrence of gastroduodenal diseases. Protein p95 (VacA), p67 (FSH), p66 (UreB), p57 (HSP homolog), p54 (flagellin), p29 (UreA), p26 and p17 seropositivity were not associated with the histological patterns of gastritis. Several studies consistently showed that different vacA genotypes are associated with disease appearance in patients from various countries. On the other hand, there are different VacA isoforms with distinct antigenic properties and consequently multiple forms of VacA could elicit the different antibody responses in H. pylori positive humans (40). Based on our findings, we can conclude that present serology testing to antigen VacA is not sensitive enough to predict toxic and histolopathological effects of vacuolisating toxin. Obviously distinct serological response to VacA toxin cannot distinct between more and less toxic isoforms of VacA related with different grades of histopathological findings. Better results in this field of research could be provided with investigation of different vacA genotypes in relation with presence of various histopathological findings. Also, none of the tested serologic markers have been associated with appearance of atrophic gastritis. It may be necessary to look for other antigens, or the atrophy could be unrelated to serologic status to H. pylori virulence antigens. In the present work, we found that only antibodies to the protein p95 (VacA) were more frequently present in patients suffering from duodenal ulcers than other endoscopic findings. Thus the anti-VacA antibody is a more powerful marker of ulcers than anti-CagA. This is not surprising, because the vacuolisating toxin has been suspected to be involved in the development of mucosal ulcerous lesions (41-43). It has been reported in earlier studies that the toxin causes epithelial damage, but appears to have little effect on inflammatory cell infiltration. These results are in agreement with previous works representing that anti-CagA, anti-VacA and anti-p35 appears to be the best markers of ulcers (44). However, the clinical relevance of this association remains controversial (45). Contrary to this, we found no association of anti-CagA antibodies to endoscopic finding. Explanation of results discrepancy could be due the fact that in some areas there is high prevalence of CagA and VacA positive patients. In our study 91.3% of patients were CagA and 75.8% VacA positive and larger group of patients is needed to validate possible difference. Another explanation could be the fact that peptic ulcers may be intermittently present and certain patients may be non – ulcerous at the time of endoscopic examination but may later evolve to an ulcerous state. Other authors have attempted to establish correlations between certain antibody patterns and gastric cancer (31). We also found anti- p95 (VacA) to be less frequently detected in patients with endoscopic finding of gastric carcinoma or normal mucosa than peptic ulcer. Possible clinical implications of observed phenomena could be used in future in order to distinguish patients infected with more virulent strains of bacteria especially in those patients infected with therapy resistant strains. Also proteins which elicit strong serological response in higher number of patients could be possibly used as a part of anti H. pylori vaccine. But, in order to confirm its real prognostic significance and clinical usefulness of these observations, a larger study population is necessary. No sample size calculation or power analysis was performed that is a possible limitation of the study. Marginal results of statistical significance were observed in difference of distributions of various grades corpus inflammation and intestinal metaplasia according to anti- p 120 (CagA) finding (P=0.087 and P=0.114 respectively, data not shown). Additional investigation with higher number of patients could answer the question of true association of protein CagA and histopathological patterns of gastritis. Moreover, presence of the bacterial virulence antigens was evaluated indirectly by host serological response only. Many of tested bacterial virulence antigens are highly immunogenic and can induce antibody response in almost all patients (46). But, it is generally known that serological response depends on antigen type and immunological reactivity of the host. Some patients are infected with more than one type of bacteria possessing a variety of different (more or less virulent) proteins encoded by different genotypes of virulence genes. All of this explains why negative serological response does not always implicate that H. pylori negativity to tested virulence antigen. Seropositivity to specific antigen does not absolutely indicate the relationship with pathogenesis of specific disease. Furthermore, these observations lead to the direction for future investigations in pathogenesis of gastroduodenal diseases. In conclusion, histological parameters of gastritis show better association with bacterial virulence than an endoscopic finding. But, no single entity or array of antigens has yet been identified that can serve as a serological marker(s) for predicting the development of specific gastric disease. This could be attributed to the role of other factors that govern disease expression for example, other undetected virulence antigens, changes in gastric physiology or host immune-inflammatory response (47). References Blaser MJ. Science, medicine, and future: Helicobacter pylori and gastric diseases. Br Med J. 1998;316(7143):1507-1510. HYPERLINK "http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Strnad%20M%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"Strnad M, HYPERLINK "http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Presecki%20V%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"Presecki V, HYPERLINK "http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Babus%20V%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"Babus V, HYPERLINK "http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Turek%20S%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"Turek S, HYPERLINK "http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Dominis%20M%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"Dominis M, HYPERLINK "http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Kaleni%C4%87%20S%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"Kalenic S, et al. Epidemiology of Helicobacter pylori infection. HYPERLINK "javascript:AL_get(this,%20'jour',%20'Lijec%20Vjesn.');"Lijec Vjesn. 2002;124(1):5-9. Kolk H. HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/15495287?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum"Evaluation of symptom presentation in dyspeptic patients referred for upper gastrointestinal endoscopy in Estonia. Croat Med J. 2004;45(5):592-598. Blaser MJ. Ecology of Helicobacter pylori in the human stomach. J Clin Invest. 1997;100(4):759-762. Jakic-Razumovic J, HYPERLINK "http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Tentor%20D%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"Tentor D, Kusec V, Cuzic S, Brkic T. Histopathological features of gastritis before and after treatment for Helicobacter pylori. Croat Med J. 2000;41(2):159-162. Brenner H, Arndt V, Stürmer T, Stegmaier C, HYPERLINK "http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Ziegler%20H%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"Ziegler H, HYPERLINK "http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Dhom%20G%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"Dhom G. Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer. 2000;88(2):274-279. Enrothy H, Kraaz W, Engstrand L, Nyrgen G, Rohan T. Helicobacter pylori strain types and risk of gastric cancer: a case-control study. Cancer Epidemiol Biomarkers Prev. 2000;9(9):981-985. Maeda S, Yoshida H, Ogura K. Assessment of gastric carcinoma risk associated with Helicobacter pylori vary depending on the antigen used: CagA specific enzyme- linked immunoadsorbent assay (ELISA) versus commercially available Helicobacter pylori ELISAs. Cancer. 2000;88(7):1530-5. Pan ZJ, van der Hulst RW, Tytgat GN, Dankert J, van der Ende A. Relation between vacA subtypes, cytotoxin activity, and disease in Helicobacter pylori- infected patients from Netherlands. Am J Gastroenterol. 1999;94(6):1517-1521. Van Doorn LJ, Figueiredo C, Sanna R, Blaser MJ, Quint WG. Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes. J Clin Microbiol. 1999(7);37:2306-2311. Sadakane Y, Kusaba K, Nagasawa Z, Tanabe I, Kuroki S, Tadano J. Prevalence and genetic diversity of cagD, cagE and vacA in Helicobacter pylori strains isolated from Japanese patients. Scand J Gastroentrol. 1999;34(10):981-6. Slater E, Owen RJ, Wiliams M, Pounder RE. Conservation of the cag pathogenicity island of Helicobacter pylori: associations with vacuolating cytotoxin allele and IS605 diversity. Gastroentrology. 1999;117(6):1308-15. Van Doorn NEM, Namavar F, van Doorn LJ, Durrani Z, Kupiers EJ, Vandenbroucke- Grauls CMJE. Analysis of vacA, cagA and IS605 genotypes and those determined by PCR amplification of DNA between repetitive sequences of Helicobacter pylori strains isolated from patients with nonulcer dyspepsia or mucosa-associated lymphoid tissue lymphoma. J Clin Microbiol. 1999;37(7):2348-2349. Domingo D, Alarcon T, Prieto N, Sanchez I, Lopez-Brea M. cagA and vacA status of Spanish Helicobacter pylori clinical isolates. J Clin Microbiol. 1999;37(6):2113-2114. Telford J L, Ghiara P, Dell’Orco M, Comanducci M, Burroni D, Bugnoli M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med. 1994;179(5):1653–1658. Blaser M J, Perez-Perez G, Kleanthous H, Cover T L, Peek R M, Chyou P H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995;55(10):2111–2115. Covacci A, Censini S S, Bugnoli M, Petracca R, Burroni D, Machia G, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci. 1993;90(12):5791–5795. Cover T L, Glupczynski Y, Lage A P, Burette A, Tummuru M K R, Perez-Perez G I, et al. Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol. 1995;33(6):1496–1500. Kreuning J, Lindeman J, Biemond I, Lamers C B H. Relation between IgG and IgA antibody titers against Helicobacter pylori in serum and severity of gastritis in asymptomatic subjects. J Clin Pathol. 1994;47(3):227–231. Klaamas K, Held M, Wadström T, Lipping A, Kurtenkov O. IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer. 1996;67(1):1–5. Bazillou M, Fendri C, Castel O, Ingrand P, Fauchčre J L. Serum antibody response to the superficial and released components of Helicobacter pylori. Clin Diagn Lab Immunol, 1994;1(3):310–317. Mitchell H M, Hazell L S L, Kolesnikow T, Mitchell J, Frommer D. Antigen recognition during progression from acute to chronic infection with a cagA-positive strain of Helicobacter pylori. Infect Immun. 1996;64(4):1166–1172. Schumann C, Triantafilou K, Rasche FM, Moricke A, Vogt K, Triantafilou M, et al. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease. Int J Med Microbiol. 2006;296(4-5):223-8. Aucher P, Petit ML, Mannant PR, Pezennec L, Babin P, Fauchere JL. Use of immunoblot assay to define serum antibody patterns associated with Helicobacter pylori infection and with H. pylori-related ulcers. J Clin Microbiol. 1998;36(4):931–936. www.wma.net/e/ethicsunit/helsinki.htm HYPERLINK "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Dixon+MF%22%5BAuthor%5D" \o "Click to search for citations by this author."Dixon MF, HYPERLINK "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Genta+RM%22%5BAuthor%5D" \o "Click to search for citations by this author."Genta RM, HYPERLINK "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Yardley+JH%22%5BAuthor%5D" \o "Click to search for citations by this author."Yardley JH, HYPERLINK "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Correa+P%22%5BAuthor%5D" \o "Click to search for citations by this author."Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20(10):1161-1181. Kuipers EJ, Schenk BE, Meuwissen SG. Helicobacter pylori: who is positive and who is not? Eur J Gastroenterol Hepatol. 1995;7(6):533-6. Covacci A, Censini S S, Bugnoli M, Petracca R, Burroni D, Machia G, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci. 1993;90(12):5791–5795. Cover T L, Glupczynski Y, Lage A P, Burette A, Tummuru M K R, Perez-Perez G I, et al. Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol. 1995;33(6):1496–1500. Kreuning J, Lindeman J, Biemond I, Lamers C B H. Relation between IgG and IgA antibody titers against Helicobacter pylori in serum and severity of gastritis in asymptomatic subjects. J Clin Pathol. 1994;47(3):227–231. Klaamas K, Held M, Wadström T, Lipping A, Kurtenkov O. IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer. 1996;67(1):1–5. HYPERLINK "http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Loffeld%20RJ%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus"Loffeld RJ, HYPERLINK "http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Werdmuller%20BF%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus"Werdmuller BF, HYPERLINK "http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Kusters%20JG%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus"Kusters JG, HYPERLINK "http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Kuipers%20EJ%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus"Kuipers EJ. Functional dyspepsia is associated with cagA-positive Helicobacter pylori strains. HYPERLINK "javascript:AL_get(this,%20'jour',%20'Scand%20J%20Gastroenterol.');"Scand J Gastroenterol. 2001;36(4):351-355. HYPERLINK "http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Vorobjova%20T%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"Vorobjova T, HYPERLINK "http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Maaroos%20HI%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"Maaroos HI, HYPERLINK "http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Uibo%20R%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"Uibo R. Immune response to Helicobacter pylori and its association with the dynamics of chronic gastritis in the antrum and corpus. HYPERLINK "javascript:AL_get(this,%20'jour',%20'APMIS.');"APMIS. 2008;116(6):465-76. Nogueira C, Figueiredo C, Carneiro F, Gomes AT, Barreira R, Figueira P, et al. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol. 2001;158(2):647-654. Warburton VJ, Everett S, Mapstone NP, Axon AT, Hawkey P, Dixon MF. Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis. J Clin Pathol. 1998;51(1):55-61. Graham DY, Genta RM, Graham DP, Crabtree JE. Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. J Clin Pathol. 1996;49(10):829-832. Sozzi M, Valentini M, Figura N, De Paoli P, Tedeschi RM, Gloghini A, et al. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status. Am J Gastroenterol. 1998;93(3):375-379. Peek RM Jr, Miller GG, Tham KT. Heightened inflammatory response and cytokine expression in vivo to CagA + Helicobacter pylori strains. Lab Invest. 1995;73(6):760-770. Audibert C, Janvier B, Grignon B. Correlation between IL-8 induction, cagA, vacA genotypes in 153 French Helicobacter pylori isolates. Res Microbiol. 2000;151(3):191-200. Perez-Perez GI, Peek RM Jr, Atherton AC, Blaser MJ, Cover TC. 1999. Detection of anti-VacA antibody responses in serum and gastric juice samples using type s1m1, s2m2 Helicobacter pylori VacA antigens. Clin Diagn Lab Immunol. 1999;6(4):489–493. Ricci V, Ciacci C, Zarrilli R, Sommi P, Tummuru M K R, Del Vecchio Blanco C, et al. Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: role of VacA and CagA. Infect Immun. 1996;64(7):2829–2833. Phadnis S H, Ilver D, Janzon L, Normark S, Westblom T U. Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect Immun. 1994;62(3):1557–1565. Veel J F L, van der Hulst R W M, Gerrits Y, Roorda P, Feller M, Dankert J, et al. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis. 1996;173(5):1171–1175. Sokic-Milutinovic A, Wex T, Todorovic V, Milosavljevic T, Malfertheiner P. Anti-CagA and anti-VacA antibodies in Helicobacter pylori-infected patients with and without peptic ulcer disease in Serbia and Montenegro. Scand J Gastroenterol. 2004;39(3):222-226. Telford J L, Ghiara P, Dell’Orco M, Comanducci M, Burroni D, Bugnoli M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med. 1994;179(5):1653–1658. Loffeld RJLF, Werdmuller BFM, Kusters JG. IgG antibody titers against Helicobacter pylori correlates with presence of cytotoxin associated gene A-positive H-pylori strains. FEMS Imunology and Medical Microbiology. 2000;28(2):139-141. Graham DY, Yamaoka Y. Disease- specific Helicobacter pylori virulence factors: the unfulfilled promise. Helicobacter. 2000;5(1):3-9. Table 1. Demographic, endoscopic, serological and patohistological findings of all 207 Croatian patients with benign and malignant gastroduodenal diseases. ParametersN (%)Age(average ± SD)54.89 ± 14.3Gendermales113 (54.6)females94 (45.4)Endoscopic findingGastric ulcer (V)46 (22.2)Duodenal ulcer (D)68 (32.8)Gastric carcinoma (C)30 (14.5)Normal mucosa (N)51 (24.6)Gastric and duodenal ulcer (VD)12 (5.8)Virulence antigenspositivenegativeP 120 (CagA)189 (91.3)18 (8.7)P 95 (VacA)157 (75.8)50 (24.2)P 67 (flagellin)83 (40.1)124 (59.9)P 66 (ureB)130 (62.8)77 (37.2)P 57 (heath shock protein homolog)149 (71.9)58 (28.1)P 54 (flagellin)50 (24.1)157 (75.9)P 3352 (25.1)155 (74.9)P 30 (outer membrane protein)57 (27.5)150 (72.5)P 29 (ureA)93 (44.9)114 (55.1)P 2687 (42.1)120 (57.9)P 19 (outer membrane protein)111 (53.6)96 (46.4)P 1776 (36.7)131 (63.3)Patohistological findingpositivenegativeCorpusInflammation201 (97.1)6 (2.9)Activity104 (50.2)103 (49.8)Atrophy15 (7.2)192 (92.8)Intestinal metaplasia23 (11.1)184 (88.9)AntrumInflammation203 (98.1)4 (1.9)Activity153 (73.9)54 (26.1)Atrophy22 (10.6)185 (89.4)Intestinal metaplasia48 (23.2)159 (76.8) Figure 1. Distribution of different grades (0- no change, 1- mild, 2- moderate, 3- marked) of histological parameters (infammation, activity, atrophy and intestinal metaplasia) of gastritis in corpus mucosa of 207 Croatian patients with benign and malignant gastroduodenal diseases.  EMBED MSGraph.Chart.8 \s  Figure 2. Distribution of different grades (0- no change, 1- mild, 2- moderate, 3- marked) of histological parameters (infammation, activity, atrophy and intestinal metaplasia) of gastritis in antrum mucosa of 207 Croatian patients with benign and malignant gastroduodenal diseases.  EMBED MSGraph.Chart.8 \s  Table 2. Presence of different grades of histological parameters of gastritis in patients serologicaly positive and negative to H. pylori virulence proteins p120 (CagA), p19, p30 (OMP) and p33 (n=207). HistologyAntibodies(( (testBivariate logistic regressiongradenegativepositivesensitivityspecificityPPOR (95% CI)p 19Intestinal metaplasia corpus0791050.0250.0050.441 (0.248-0.785)1432.7095.8321132.7088.543200.0097.92sum96111p 30 (outer membrane protein)Inflammation corpus0600.0100.0031.956 (1.252-3.055)1882747.3741.332492035.0967.55371017.5495.33sum15057p 30 (outer membrane protein)Inflammation antrum0130.0250.3671.224 (0.789-1.900)1541628.0764.002802645.6146.673151221.0590.00sum15057p 33Inflammation corpus0420.0500.0261.666 (1.061-2.616)1952038.4638.712452446.1570.97311611.5492.90sum15552p 120 (CagA)Activity antrum04500.0250.0952.295 (0.911-3.175)1147740.7422.22204724.87100.0030157.94100.00sum18189 Table 3. Serological findings to twelve H. pylori virulence antigens in various benign and malignant gastroduodenal diseases (n=207). AntigenEndoscopic finding*(( testBivariate logistic regressionDCNVVDPOR (95% CI)Pp120pos.65284342110.3010.794 (0.511-1.233)0.304neg.32841p95pos.6218363380.0061.147 (0.862-1.524)0.347neg.61215134p67pos.2411271560.2091.264 (0.981-1.628)0.070neg.441924316p66pos.4223322760.4550.854 (0.663-1.101)0.233neg.24719196p57pos.4822403090.6911.128 (0.860-1.479)0.384neg.20811163p54pos.1410131120.6800.872 (0.656-1.159)0.347neg.5420373510p33pos.145191220.1741.199 (0.902-1.593)0.211neg.5425323410p30pos.201017730.2911.092 (0.831-1.434)0.529neg.482034398p29pos.2816241960.7900.983 (0.770-1.256)0.894neg.401427276p26pos.2813281260.3911.272 (0.989-1.635)0.061neg.401723346p19pos.4111312080.0761.409 (1.094-1.814)0.008neg.271920264p17pos.2812191340.6991.023 (0.795-1.316)0.859neg.401832338 sum6830514612*C- carcinoma. D- duodenal ulcer. N- normal mucosa. V- gastric ulcer. VD- gastric and duodenal ulcer Corresponding author: Tajana Filipec Kani~aj Department of Internal medicine, University Hospital Merkur, Faculty of Medicine Zaj eva 19, 10 000 Zagreb, Croatia Tel. 0038598623903 Fax. 0038512431393 e-mail: tajana_filipec@yahoo.com     PAGE 14 &9eg¢£¬ęē÷ų   * Ÿ   ż ž k l æ ę ģÕģÄģ³ģ³¤³•³‡vgv³¤³¤³¤REh‘@Łh{ ›OJQJ^J(h‘@Łh{ ›OJQJ^JmH nHsH tHhųEH*OJQJ^JmH sH  hźx¹h{ ›OJQJ^JmH sH h{ ›OJQJ^JmH sH h.JH*OJQJ^JmH sH hźx¹H*OJQJ^JmH sH  hŪk¹h{ ›OJQJ^JmH sH  h{ ›5OJQJ\^JmH sH ,h h 56OJQJ\]^JmH sH &hŪk¹h{ ›5OJQJ\^JmH sH ¢£¬ĆÕčł  ) * Ÿ ż k ē č é = ł d¼)*{÷÷÷÷÷ģį÷÷÷÷÷÷÷Ł÷÷÷÷÷÷÷ĪĪ $dąa$gdĻ~Ŗdągd‘@Ł $dąa$gdF’ $dąa$gdvOż$dąa$¤£Ś£žžę ē č   4 < = A B D  ¢ « ¬ ł    b s † ‡  15cėŚÉµÉ”ڔɓɓµ‚É”Ém[m[mIm[m[m#hųEB*OJQJ^JmH phsH #h{ ›B*OJQJ^JmH phsH )hŪk¹h{ ›B*OJQJ^JmH phsH  h{ ›6OJQJ]^JmH sH h{ ›OJQJ^JmH sH &hŪk¹h{ ›5OJQJ\^JmH sH &h h 6OJQJ]^JmH sH  hŪk¹h{ ›OJQJ^JmH sH  h‘@Łh{ ›OJQJ^JmH sH (h‘@Łh{ ›OJQJ^JmHnHsHtHcdl•Żäåęē%&2PT\]p|‘™š¦Ŗ²³ĄĢŻįéź+/78CG‰”ŌŲ+<=S`¼Č+ļŪļŹ¼Ź¼®ļ¼ļ¼ļ¼ļ¼ļšļ¼ļ¼ļšļ¼ļšļ¼ļ¼ļšļ¼ļ¼ļšļ¼ļ¼ļ¼ļ¼ļ¼ļšļ¼ļŪļ¼ļ¼&hŪk¹h{ ›6OJQJ]^JmH sH h OJQJ^JmH sH h{ ›OJQJ^JmH sH  hgxh{ ›OJQJ^JmH sH &hŪk¹h{ ›5OJQJ\^JmH sH  hŪk¹h{ ›OJQJ^JmH sH <+ek“äś)4=z{|‰œž§Ø©ō 89Šēšń™¢T]ļįļįļÓļæ«ļļ櫉ļ«ļ‰ļ|l|eļį«Tļ«ļ« h{ ›6OJQJ]^JmH sH  hŪk¹h{ ›h h 6OJQJ]^JhŪk¹h{ ›OJQJ^J&hŪk¹h{ ›6OJQJ]^JmH sH hŪk¹h{ ›5\mH sH &h h 6OJQJ]^JmH sH &hŪk¹h{ ›5OJQJ\^JmH sH hńl®OJQJ^JmH sH h{ ›OJQJ^JmH sH  hŪk¹h{ ›OJQJ^JmH sH  {‰²/ˆ‰Š’“œB!Ź#v%w%%))!)7+÷ėėė÷÷÷÷÷ÜɶŖ÷ŖŖ÷Ÿ $dąa$gd!0ļ $dą7$8$H$a$$„Šdą7$8$H$`„Ša$gd‘›$„Šdą7$8$H$`„Ša$gd£T»$dą7$8$H$a$gdės­ $„Šdą`„Ša$$dąa$]Óšńł#ūÉŅ‚ƒ¤„™¢8AĪŻŽŠ’“œļŽÓļŽÓļÅļ±ļ±ļˆļzļzļ±ļ±ļlzļXļX&hŪk¹h{ ›5OJQJ\^JmH sH hjHįOJQJ^JmH sH h{ ›OJQJ^JmH sH )hŪk¹h{ ›B*OJQJ^JmH phsH &hŪk¹h{ ›6OJQJ]^JmH sH &h h 6OJQJ]^JmH sH hˆG?OJQJ^JmH sH hŪk¹h{ ›B*ph!hŪk¹h{ ›B*OJQJ^Jph hŪk¹h{ ›OJQJ^JmH sH œ¬Õ % V p !7!;!A!B!U!ø!Į!Ā!é!"#"$"-"."4"ņ"ó"{#„#Ē#É#ėŚĶŚėŚĶĆĶĆĶŚė«“ėŚkŚ“ėŚWŚŚIh{ ›OJQJ^JmH sH 'hŪk¹h{ ›EHž’H*OJQJ^JmH sH &hŪk¹h{ ›6OJQJ]^JmH sH &h h 6OJQJ]^JmH sH .hŪk¹h{ ›6OJQJ]^JmH nHsH tH.h h 6OJQJ]^JmH nHsH tHh{ ›OJQJ^JhŪk¹h{ ›OJQJ^J hŪk¹h{ ›OJQJ^JmH sH (hŪk¹h{ ›OJQJ^JmH nHsH tHÉ#ä$ę$w%%°&ø&–'—')!)`)s)t)u)Ī)ē)2*;*^*g*ą*ó*+$+2+3+4+g+p+x+ķ+ī+S,T,x,˜,š,½, -*-2-;-Y-a-b-ļįļĶļ¹ļįļĶļ„ļįļįļ„ļ„ļ„ļ„—ļ—ļtļįļįļ‰ļ‰ļ„‰ļt)hŪk¹h{ ›B*OJQJ^JmH phsH hEäOJQJ^JmH sH hō%ėOJQJ^JmH sH &h h 6OJQJ]^JmH sH &hŪk¹h{ ›6OJQJ]^JmH sH &hŪk¹h{ ›5OJQJ\^JmH sH h{ ›OJQJ^JmH sH  hŪk¹h{ ›OJQJ^JmH sH -b--Ž-¾-É-ā-ė-Y._.`.b.h.j.Ę.Ģ.f/g/i/k/m/p/Ž///‘/™/š/«/×/ą/é/ļįļĶļ¹ļ¦zļ¦j¦ļ\ļ\ļ\Nļ\ļĶļĶļ¹ļh OJQJ^JmH sH h{ ›OJQJ^JmH sH h{ ›KHOJQJ^JmH sH )hŪk¹h{ ›6H*OJQJ]^JmH sH , jcšhŪk¹h{ ›6OJQJ]^JmH sH $hŪk¹h{ ›KHOJQJ^JmH sH &h h 6OJQJ]^JmH sH &hŪk¹h{ ›5OJQJ\^JmH sH h[4łOJQJ^JmH sH  hŪk¹h{ ›OJQJ^JmH sH 7+½-¾-É-//‘/™/š/«/ 1>2’3>4?44(8)8n8;šččŁčččččĪææččč··čč$dąa$$„Šdą`„Ša$gdˆ" $dąa$gdŚĖ$dą7$8$H$a$gdłb²$dąa$$„Šdą`„Ša$gd!0ļé/ź/„0…0—0˜0<1=1œ11ž12=2>2[2_2‹2Œ2R3‘3’3“3ā3ļ3ń3444)4.4>4M4N4W445-5t5ņįŚįĢįņįĢįņ¾ņįņįņįņįŖįņįņįņįņįŖ“|ŖmamhŽs-CJaJmH sH hŪk¹h{ ›CJaJmH sH ,h h 56OJQJ\]^JmH sH ,hŪk¹h{ ›56OJQJ\]^JmH sH &hŪk¹h{ ›5OJQJ\^JmH sH hō%ėOJQJ^JmH sH hŽs-OJQJ^JmH sH  hŪk¹h{ › hŪk¹h{ ›OJQJ^JmH sH h{ ›OJQJ^JmH sH %t5u5†5ˆ5Ņ5Ó5ē5č5&6'6Æ6°68 8(8)87888A8L8S8n8#9$9īßÓßīßīßīßīßĒßµ”Šs”b”Q=&hŪk¹h{ ›6OJQJ]^JmH sH  hŪk¹h{ ›OJQJ^JmH sH  h{ ›5OJQJ\^JmH sH ,h h 56OJQJ\]^JmH sH ,hŪk¹h{ ›56OJQJ\]^JmH sH &hŪk¹h{ ›5OJQJ\^JmH sH "hŪk¹h{ ›5CJ\aJmH sH h{ ›CJaJmH sH hŽs-CJaJmH sH hŪk¹h{ ›CJaJmH sH "hŪk¹h{ ›6CJ]aJmH sH $9+9-9I9L9U9]9^9e9i9s9t9u9x9¤9„9¦9«9¼9Ė9Ī9å9ę9ķ9:!:J:R:Z:a:z:ˆ:‰:”:Ŗ:ņäÓ± ± ±Ā±ĀӏӠӠ~ÓĀÓ± ±~±Āpä_ hŪk¹h{ ›OJQJ^JmH sH hāĀOJQJ^JmH sH  h:¤h[4łOJQJ^JmH sH  h:¤hFHcOJQJ^JmH sH  h:¤hÆrTOJQJ^JmH sH  h:¤hŪƒOJQJ^JmH sH  h:¤hj!„OJQJ^JmH sH  h:¤hāĀOJQJ^JmH sH h¬śOJQJ^JmH sH h‹B„OJQJ^JmH sH "Ŗ:ø:Š:Ł:ķ:ń:;;I;R;S;V;i;ƒ;Ž;“;§;¶;Ŗ<­<9=B=S=X=€=‰=Ø=©=Ü=å=2>źŁÅŁźŁ·ŁÅ£Ł·ŁŁŁŁÅفŁnŁ\ŁÅŁ#hŪk¹h{ ›H*OJQJ^JmH sH $h h 0J!OJQJ^JmH sH h{ ›OJQJ^JmH sH &hŪk¹h{ ›5OJQJ\^JmH sH &hŪk¹h{ ›6OJQJ]^JmH sH h¬śOJQJ^JmH sH &h h 6OJQJ]^JmH sH  hŪk¹h{ ›OJQJ^JmH sH )hŪk¹h{ ›B*OJQJ^JmH phsH ;‚;ƒ;Ž;ī<9>ĪCōGāHEQįVŪXÜXŻXčX`Y+_q`Õ`\bšššŻŻĒĒ“ŻŻŻšš¬§§§§§gdMY«$dąa$$„Šdą7$8$H$`„Ša$gd>„($„Šdत[$\$`„Ša$gdąy($„Šdत[$\$`„Ša$($dत[$\$a$2>3>5>6>_>h>y>™>@@@@@,@5@6@9@J@t@|@ą@į@ć@ä@‚AƒA“A—A¾AæAĢAÓAŽAéABBBB&B)B«B“BµBņįņįĶįæį±į±į±Ÿį±įįņįņįņįqįqįqįqįņįņįqįįh{ ›OJQJ^JmH sH hąyOJQJ^JmH sH #h‹B„h‹B„6OJQJ^JmH sH #h h 6OJQJ^JmH sH h‹B„OJQJ^JmH sH hųEOJQJ^JmH sH &h h 6OJQJ]^JmH sH  hŪk¹h{ ›OJQJ^JmH sH hō%ėOJQJ^JmH sH *µB¶B·BČBŃBęBļBüB’BC*C7CIChCiCŒCC—C§C±CµCĆCĢCĶCĪCźCņįŠ¾Š­ŠįœŠœ‹œzœŠįŠiŠiŠ‹[J h>„h{ ›OJQJ^JmH sH hąyOJQJ^JmH sH  h:¤hEäOJQJ^JmH sH  h:¤hŒOJQJ^JmH sH  h:¤h;$„OJQJ^JmH sH  h:¤hąyOJQJ^JmH sH  h:¤h\7ŠOJQJ^JmH sH #h:¤h 6OJQJ^JmH sH  h:¤hBTFOJQJ^JmH sH  h:¤h:¤OJQJ^JmH sH h:¤OJQJ^JmH sH źCėCDDD5DCDDDWDnDƒD¦DØD®DøD¼DÅDĘDĒDŹD#E$EĆEĢEĶEßEąEųEłEoFpF˜F™FźŁĖ½ŁÆŁ”Ł”ŁĖŁ“ٓٓŁĖŁkŁ]ŁĖٽŁĖhō%ėOJQJ^JmH sH &h h 6OJQJ]^JmH sH &h>„h{ ›6OJQJ]^JmH sH hFOJQJ^JmH sH hKZ¢OJQJ^JmH sH hž@LOJQJ^JmH sH hųEOJQJ^JmH sH h{ ›OJQJ^JmH sH  h>„h{ ›OJQJ^JmH sH )h>„h{ ›B*OJQJ^JmH phsH  ™FõFśF¤GØG³G¾GÄGŠGóGōG)HFHGH†HˆHÄHĶHāH II#I/I4IDIMIvIIļŽļŹļ¼ļ¼ļ®¼®®‰xj\xjxjxNhS‰OJQJ^JmH sH hZ*äOJQJ^JmH sH hū@ÜOJQJ^JmH sH  hŪk¹h{ ›OJQJ^JmH sH &h h 6OJQJ]^JmH sH  h>„h{ ›OJQJ^JmH sH h{ ›OJQJ^JmH sH h”OJQJ^JmH sH &häOBh{ ›6OJQJ]^JmH sH  häOBhųEOJQJ^JmH sH  häOBh{ ›OJQJ^JmH sH I•I™IžIrJsJuJvJ”K¢K»KŲKńKņKżKLLLÕLŲLTM^M×MŲM”N¢N¤N„NøN¹NÅN’NOņįÓįÅįÅįÅį·įÅį©į·į·į˜į©įÅį†uduSu h:¤hÉŚOJQJ^JmH sH  h:¤hŽ)7OJQJ^JmH sH  h:¤h{ ›OJQJ^JmH sH #hŪk¹h{ ›H*OJQJ^JmH sH  hŪk¹hÉŚOJQJ^JmH sH h{ ›OJQJ^JmH sH hW#,OJQJ^JmH sH hō%ėOJQJ^JmH sH hŌPÄOJQJ^JmH sH  hŪk¹h{ ›OJQJ^JmH sH hFOJQJ^JmH sH  O>OaObO€O¤O”PŖP QHQ`QbQcQiQuQ€Q„QˆQŠQļŽĢŽ»Ŗ–Ŗ…tct…R…AtA h@)Ėh:¤OJQJ^JmH sH  h@)Ėh\7ŠOJQJ^JmH sH  h@)ĖhnWCOJQJ^JmH sH  h@)Ėh¼0wOJQJ^JmH sH  h@)Ėh{ ›OJQJ^JmH sH &h h 6OJQJ]^JmH sH  hŪk¹h{ ›OJQJ^JmH sH  h:¤hW#,OJQJ^JmH sH #h:¤h{ ›H*OJQJ^JmH sH  h:¤h{ ›OJQJ^JmH sH  h:¤hÉŚOJQJ^JmH sH ŠQQŖQ«QµQ½QŁQēQRR RRRERFRRRSRYRfRoRpR{RļŽĶKšļšļ‰xgļVļšVšDš#h@)Ėhk;Ÿ6OJQJ^JmH sH  h@)Ėh\7ŠOJQJ^JmH sH  h@)ĖhnWCOJQJ^JmH sH  h@)ĖhŽ)7OJQJ^JmH sH  h@)Ėh¶µOJQJ^JmH sH  h@)Ėhk;ŸOJQJ^JmH sH  h@)ĖhÉŚOJQJ^JmH sH  h@)Ėh{ ›OJQJ^JmH sH  h@)ĖhZÅOJQJ^JmH sH  h@)ĖhųEOJQJ^JmH sH  h@)Ėh+<óOJQJ^JmH sH {R|R}R¢RŗRŚRąR1S2SDSESMSOSiS|S}SŠS•S˜S±SøSķÜĖŗ©˜©‡©vevTvTvTvC˜ h@)ĖhĖ^OJQJ^JmH sH  h@)ĖhšMśOJQJ^JmH sH  h@)Ėh¶µOJQJ^JmH sH  h@)Ėh{ ›OJQJ^JmH sH  h@)Ėh¼0wOJQJ^JmH sH  h@)Ėh+<óOJQJ^JmH sH  h@)ĖhG9ŌOJQJ^JmH sH  h@)ĖhŽ)7OJQJ^JmH sH  h@)Ėhk;ŸOJQJ^JmH sH  h@)ĖhFHcOJQJ^JmH sH #h@)ĖhFHc6OJQJ^JmH sH øS¹SŪSāSūS TTT2T8T9T>TŖT°T±TUeUmUyUzU{UļŽĶŽĶ¼«¼ļĶļš‰xgVE4«š h@)ĖhŽ)7OJQJ^JmH sH  h@)ĖhFHcOJQJ^JmH sH  h@)ĖhŌioOJQJ^JmH sH  h@)ĖhŅKżOJQJ^JmH sH  h@)ĖhbOJQJ^JmH sH  h@)Ėh*OJQJ^JmH sH  h@)ĖhĖ^OJQJ^JmH sH  h@)ĖhZÅOJQJ^JmH sH  h@)ĖhnWCOJQJ^JmH sH  h@)ĖhšMśOJQJ^JmH sH  h@)Ėh{ ›OJQJ^JmH sH  h@)Ėh:¤OJQJ^JmH sH {U}U„U¬U»U¾UÄUÅUĢUĻUÓUŚUėUķUīUVVV$V,V-V1VCVSV\VcVeVpV…VVšV”V¢VļŽĶŽ»©˜Ž˜ŽĶļŽ˜ŽĶŽĶ‡veŽvŽĶޘvĶT˜v h@)ĖhŽ)7OJQJ^JmH sH  h@)ĖhŌPÄOJQJ^JmH sH  h@)ĖhŅKżOJQJ^JmH sH  h@)Ėhk;ŸOJQJ^JmH sH  h@)Ėh@)ĖOJQJ^JmH sH #h@)Ėh:¤6OJQJ^JmH sH #h@)Ėh 6OJQJ^JmH sH  h@)ĖhŌioOJQJ^JmH sH  h@)ĖhĖ^OJQJ^JmH sH  h@)ĖhZÅOJQJ^JmH sH  ¢V„VČV×VąVįVW,WKWaW×XŲXÜXēXčXYļŽĶ޼«Œ«{m{YA6h éh{ ›mH sH /hŪk¹h{ ›5B*OJQJ\^JmH phsH &hŪk¹h{ ›5OJQJ\^JmH sH hĻqOJQJ^JmH sH  hŪk¹h{ ›OJQJ^JmH sH  h@)Ėh±/äOJQJ^JmH sH h@)ĖOJQJ^JmH sH  h@)Ėh{ ›OJQJ^JmH sH  h@)ĖhŌioOJQJ^JmH sH  h@)ĖhnWCOJQJ^JmH sH  h@)ĖhŅKżOJQJ^JmH sH  h@)Ėh@)ĖOJQJ^JmH sH Y%Y*B*^JmH ph’sH jh³öUh 60h{ ›mH sH jh{ ›Uh hŁN?mH sH h h{ ›mH sH h éh{ ›mH sH h h 6]mH sH *ƒ^„^…^Ž^^Ø^»^Ē^Č^ _ _ ____*_,_4_5_Ś_Ū_Ü_N`O`P`[`ōģ×ģ̾Ģ쳨ģ“ģˆyjĢģ³_ģĢģĢPhŁN?h{ ›0J0^JmH sH jS h³öUhŪk¹h{ ›0J/^JmH sH hÄ4h{ ›0J/^JmH sH h hŁN?mH sH (hÄ4h{ ›0J >*B*^JmH ph’sH jh h³öUh 60h{ ›mH sH h h 6]mH sH h éh{ ›mH sH (h éh{ ›0J >*B*^JmH ph’sH jh{ ›UjM h³öU[`\`p`q`‡`š`›`±`¾`æ`Č`Ė`Ō`Õ`č`é`·aøa¹aĮaĀaŻa&b9b;bFbGbńę×̾°ĢØ ••ę‚w‚iw‚w‚Ģ]ĢRJhŁN?mH sH h#2Zh{ ›mH sH h h 6mH sH jh:1h³öUjh:1h{ ›Uh:1h{ ›mH sH h{ ›mHsHhŪk¹h{ ›mHsHhŁN?mHsHhoŹmHsHh éh{ ›6]mH sH h h 6]mH sH h éh{ ›mH sH hŪk¹h{ ›0J/^JmH sH hŁN?h{ ›mH sH hŁN?hŁN?0J0^JmH sH Gb[b\bˆb‰bXcYcZcccdcfcgc3d4d5d;ddvd‰d¼d½dÅdČdŃdÓdeķā×ĻĹĻ×Ļ×ĻÄ®Ļ×ĻŽmaUāJh éh{ ›mH sH h{ ›B*mH phsH hŁN?B*mH phsH #h h 6B*]mH phsH hŪk¹h{ ›B*mH phsH hŪk¹h{ ›B*mHphsH hŪk¹h{ ›OJQJ^JmHsHj0h³öUjh³öUhFHch{ ›mHsHjh{ ›UhŪk¹h{ ›mHsHhŪk¹h{ ›mH sH $h#2Zh{ ›0J$CJ^JaJmH sH \bÓde©fgBh#iüiuklólšmļn¶opbq!rsšsćt uēxoyoz6{|į|śśśśśśśśśśśśśśļśśļśśļįśśśļ$ & Fdąa$gdA)‘ $ & Fdąa$gdMY«eeZeze{eeįeōerf…fŽf”f•f©fśfžf,g?gegwgxggĒgÉgŽgńgögh*h+hBh¦hŖh¬h°hµh¹h½hŠhśhii#iaidi}iiÅiŹiÖiåięiWjcjgjijmjrjwjÓjęjMk]kņēÜŃÜēņēņēÜŃÜēĆēņēÜŃÜø°ēņĆē„„ēĆēĆēĆēņēÜŃÜēĆēņēĆēÜŃÜēĆēĆēĆēņēÜhŁN?mH sH h#2Zh{ ›mH sH h{ ›mHsHh°Vh{ ›mHsHh éh{ ›6]mH sH hŁN?hŁN?mH sH hŁN?h{ ›mH sH h éh{ ›mH sH h h 6]mH sH >]k^kuk®k²k·k»kĪkįkõklllll‚l•lŃlŚlŪlÜlįlälēlRmemym}mĶm×mŲmŁmŽmąmämšm;nnõźßŃßŃßĆßźõźøß©ßšŽšß|mß©ß^ߚŽšß|mßøßhŪk¹h{ ›0J!^JmH sH h{ ›0J#5\^JmH sH "hŪk¹h{ ›0J#5\^JmH sH hŁN?0J"^JmH sH hŪk¹h{ ›0J"^JmH sH h h 0J!^JmH sH hŪk¹h{ ›mHsHh h 6]mH sH h éh{ ›6]mH sH h éh{ ›mH sH hŁN?h{ ›mH sH hŁN?hŁN?mH sH $n’nÄnÖn×nŲnŻnßnćnkooopoqo„oŽožoŸo o„o§oŖop/pmpzp{p|ppƒp†ppŽpńpCqńę×Ė×ę¹Ŗę›†ńę×Ė×ę¹Ŗęńę×Ė×{¹Ŗ{jWj$h h 0J!OJQJ^JmH sH  hŪk¹h{ ›OJQJ^JmH sH hŁN?h{ ›mH sH h H*mH sH h éh{ ›H*mH sH hŪk¹h{ ›0J!^JmH sH h{ ›0J#5\^JmH sH "hŪk¹h{ ›0J#5\^JmH sH hŁN?0J"^JmH sH hŪk¹h{ ›0J"^JmH sH h éh{ ›mH sH h h 0J!^JmH sH !CqOqPqQqVqXq[qbqįqōqöq r rrrrr!r°r“rķŻķ̶£Ģ˜‰˜znzcQBc˜3hŪk¹h{ ›0J!^JmH sH h{ ›0J#5\^JmH sH "hŪk¹h{ ›0J#5\^JmH sH h h{ ›mH sH hŁN?0J"^JmH sH hŪk¹h{ ›0J"^JmH sH h h 0J!^JmH sH h éh{ ›mH sH $h{ ›0J#5OJQJ\^JmH sH *hŪk¹h{ ›0J#5OJQJ\^JmH sH  hŪk¹h{ ›OJQJ^JmH sH hŁN?0J"OJQJ^JmH sH $hŪk¹h{ ›0J"OJQJ^JmH sH “rČrŪrŻrérėršrņrõrsysŒsŁsŚsšs2t|tt£t¬t½tĶtĪt uõęõ×ĖĄ®ŸĄŽ|ŽnŽcõWõWõLALhŁN?hŁN?mH sH hŁN?h{ ›mH sH h h 6mH sH hŪk¹h{ ›mH sH hŁN?OJQJ^JmH sH #h h 6OJQJ^JmH sH  hŪk¹h{ ›OJQJ^JmH sH h{ ›0J#5\^JmH sH "hŪk¹h{ ›0J#5\^JmH sH h h{ ›mH sH hŁN?0J"^JmH sH hŪk¹h{ ›0J"^JmH sH h h 0J!^JmH sH h éh{ ›mH sH  u uÅuĘuĒuĻuŠuŅuÓuŽvvv˜v™v›vœvYwZw[wewfwhwiw$x%x&x.x/x¾xĪxĻxēxīxļxńxóxłxśxüxžxyy÷óč÷×÷×÷óĢ÷×÷×÷óĮ÷×÷×÷ó¶÷×÷ן‹Ÿzizizizizi hŪk¹h{ ›OJQJ^JmHsH h>:h{ ›OJQJ^JmHsH&hŁN?0J$CJOJQJ^JaJmH sH ,hŪk¹h{ ›0J$CJOJQJ^JaJmH sH jČh³öUjAh³öUj¾h³öU hŪk¹h{ ›OJQJ^JmH sH j;h³öUh{ ›jh{ ›U)y y yyAyDyEyFyGyTyUy\y^yoyŗyžyzCzUzVzWz\zļŽĪĮ®›®›®›®ŽŠtetVJVthŁN?0J"^JmH sH hŪk¹h{ ›0J"^JmH sH h h 0J!^JmH sH h éh{ ›mH sH hŪk¹h{ ›mHsH hŪk¹h{ ›OJQJ^JmHsH$hŪk¹h{ ›0J0OJQJ^JmHsH$hŪk¹h{ ›0J0OJQJ^JmH sH hŪk¹h{ ›OJQJ^Jh h 6OJQJ]^J hŪk¹h{ ›OJQJ^JmHsH h>:h{ ›OJQJ^JmHsH\z^zbzėzļzńz{{ {%{'{*{œ{Æ{ķ{ś{ü{||||^|q|Ć|Ļ|īßŌŹŖŌžŌīßŌŖŌž„ī߄s`sM$hŪk¹h{ ›0J"OJQJ^JmH sH $h h 0J!OJQJ^JmH sH  hŪk¹h{ ›OJQJ^JmH sH h h{ ›mH sH hŪk¹h{ ›0J"^JmH sH hŁN?0J"^JmH sH h h 0J!^JmH sH h éh{ ›H*mH sH hŪk¹h{ ›0J!^JmH sH h éh{ ›mH sH h{ ›0J#5\^JmH sH "hŪk¹h{ ›0J#5\^JmH sH Ļ|Š|Ń|Ö|Ų|Ū|į|ā|œ}}ž}Ø}©}«}¬}i~j~k~x~y~{~|~678BCEF€šŻĢ¶£Ģ›—Œ›s›b›—W›s›b›—L›s›b›—jh³öUj2h³öU h>:h{ ›OJQJ^JmHsH0h°Vh{ ›0J >*B*OJQJ^JmHph’sHjKh³öUh{ ›jh{ ›U$h{ ›0J#5OJQJ\^JmH sH *hŪk¹h{ ›0J#5OJQJ\^JmH sH  hŪk¹h{ ›OJQJ^JmH sH $hŪk¹h{ ›0J"OJQJ^JmH sH hŁN?0J"OJQJ^JmH sH €€€ € €€E€X€b€c€±€²€³€Č€É€Ź€ß€ą€±²³¾æōģÓ챟±ģ›ģwģs`ģUJģ9ģ hŪk¹h{ ›OJQJ^JmH sH jģ#h³öUhFHch{ ›mH sH $hŪk¹h{ ›0J/OJQJ^JmH sH hŁN?0hŪk¹h{ ›0J >*B*OJQJ^JmH ph’sH jķ"h³öUh{ ›#h h 6OJQJ^JmH sH  hŪk¹h{ ›OJQJ^JmH sH  h>:h{ ›OJQJ^JmHsH0h°Vh{ ›0J >*B*OJQJ^JmHph’sHjh{ ›Uj!h³öUį|߀N„…˅܆ø‡`ˆ ‰ŠīŠŗ‹­ŒÆ…Žpõ’ģÖŃŃŃŃŃŃĮŃŃŃŃŃѶ«¢ $Ifgd:I $dąa$gdų|R $ & Fdąa$$ & Fdą7$8$H$a$gdMY«$ & F„€„›ždą^„€`„›ža$gd÷S$ & F„€„›ždą^„€`„›ža$æĮĀ’‚“‚”‚ž‚Ÿ‚”‚¢‚nƒoƒpƒvƒwƒyƒŒƒŸƒõƒöƒ0„1„2„7„8„9„M„N„„°„ļēÜŃēļēļēÜĘēļē﹩¹ē„šē…ēn¹cWh h 6mH sH h>:h{ ›mHsH$hŪk¹h{ ›0J$CJOJQJ^JaJhŁN?(hŪk¹h{ ›0J >*B*OJQJ^Jph’j*h³öUh{ ›h h 6OJQJ]^JhŪk¹h{ ›OJQJ^Jj(h³öUj&h³öUhFHch{ ›mH sH jh{ ›U hŪk¹h{ ›OJQJ^JmH sH °„ģ„ķ„‹…ž…Ŗ…·…ø…ų…™†¬†ø†Å†Ę†Ü†(‡X‡k‡¢‡£‡ˆˆ#ˆ6ˆ7ˆJˆKˆ¦ˆŖˆ¬ˆ°ˆÉˆÜˆēˆōˆõˆ ‰²‰Å‰õķõįõÖĖÖõįõÖĖÖĄõįõøõŖõœŖõøõŖõŖõœõÖĖ֋w&h h 6OJQJ]^JmH sH  hŪk¹h{ ›OJQJ^JmH sH h h 6]mH sH h éh{ ›6]mH sH h%&mH sH hŪk¹h{ ›mHsHh%&h%&mH sH h%&h{ ›mH sH h h 6mH sH hŁN?mH sH h éh{ ›mH sH &ʼnƉć‰ė‰ģ‰ŠTŠ^ŠqŠŹŠÖŠ×ŠŲŠŻŠßŠāЁ‹”‹–‹¢‹¤‹©‹«‹®‹ŗ‹bŒuŒˆŒ”Œ•Œ–ŒģŽĶæĶ“©š©‹‹©m^©š©‹Sm^S©š©‹‹h h{ ›mH sH h{ ›0J#5\^JmH sH "hŪk¹h{ ›0J#5\^JmH sH h%&0J"^JmH sH hŪk¹h{ ›0J"^JmH sH h h 0J!^JmH sH h éh{ ›mH sH hŪk¹h{ ›mHsHh%&OJQJ^JmH sH  hŪk¹h{ ›OJQJ^JmH sH hoŹOJQJ^JmH sH &hŪk¹h{ ›6OJQJ]^JmH sH –Œ›ŒžŒ”Œ­Œ1„™š ®Æ¹žŽ'ŽcŽlŽmŽnŽsŽvŽyބޅކŽõćŌõɽɮ¢®“õ‹€ÉqÉbVbÉćŌÉNChŌ hŌ mH sH h{ ›mH sH h%&0J"^JmH sH hŪk¹h{ ›0J"^JmH sH h h 0J!^JmH sH hŪk¹h{ ›mHsHh mHsHhŪk¹h{ ›0J/^JmH sH h%&0J.^JmH sH hŪk¹h{ ›0J.^JmH sH h h 6mH sH h éh{ ›mH sH h{ ›0J#5\^JmH sH "hŪk¹h{ ›0J#5\^JmH sH h%&h{ ›mH sH †ŽÆŽ°ŽĢŽßŽ!)op˜«Åäåģļõ‘’œļŻĪ¼Ī«Ī ‘‘sg‘[‘PHP;hæ(¶h^m¼OJQJ^JhDr*CJaJhŪk¹h{ ›CJaJh{ ›CJaJmH sH h%&CJaJmH sH hØ5öCJaJmH sH "h h 6CJ]aJmH sH hŪk¹h{ ›CJaJmH sH hŌ hŌ mH sH  hŌ hŌ 6B*mH phsH #h h 6B*]mH phsH hŌ hŌ B*mH phsH #hŌ hŌ 5B*\mH phsH  hŌ hŌ B*\mH phsH œŸ”¢£¤§Ø³µ¶ÄÅĖĢĶŃŅŪŻŽßąęēļńņóō‘‘‘‘$‘%‘.‘B‘C‘K‘`‘a‘c‘d‘k‘€‘‘‰‘Ŗ‘«‘¬‘­‘æ‘Ņ‘óéóßóŲĖóĖĮĖóŲĖóéĖó·óŲóéĖó·óŲóŲĖóŲĖŖ£ĖŖ£ĖŖ™Ŗ£ĖŖ£ĖŖ£óŲˌhæ(¶h{ ›OJQJ^Jhq'ŹOJQJ^J hæ(¶hq'Źhæ(¶hq'ŹOJQJ^JhÄ4OJQJ^JhJBOJQJ^Jhæ(¶h^m¼OJQJ^J hæ(¶hÄ4h:IOJQJ^Jh·EaOJQJ^Jhæ(¶hÄ4OJQJ^J6£¤Ø·Äóneeó $Ifgd:I…kdž*$$IfÖ”’Ö0ń’ó„#€$‰ €$’Ö0’’’’’’öˆ6ööÖ’’Ö’’Ö’’Ö’’2Ö 2Ö2Ö 2Ö4Öaö $$Ifa$gd:IĐŐ̐Ґݐ^UUI $$Ifa$gd:I $Ifgd:I”kdČ+$$IfÖ”’ÖFń’Ió„#€$c€$& €$’Ö0’’’’’’öˆ6ööÖ ’’’Ö ’’’Ö ’’’Ö ’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaöݐސߐēń^UUI $$Ifa$gd:I $Ifgd:I”kdŗ,$$IfÖ”’ÖFń’Ió„#€$c€$& €$’Ö0’’’’’’öˆ6ööÖ ’’’Ö ’’’Ö ’’’Ö ’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaöńņó^U $Ifgd:I”kd¬-$$IfÖ”’ÖFń’Ió„#€$c€$& €$’Ö0’’’’’’öˆ6ööÖ ’’’Ö ’’’Ö ’’’Ö ’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaöóō‘‘‘–$ikd@/$$IfÖ”’Öń’„#€$ˆÖ0’’’’’’öˆ6ööÖ’Ö’Ö’Ö’2Ö 2Ö4Öaö $Ifgd:Iikdž.$$IfÖ”’Öń’„#€$ˆÖ0’’’’’’öˆ6ööÖ’Ö’Ö’Ö’2Ö 2Ö4Öaö‘$‘%‘8‘B‘óneó $Ifgd:I…kdā/$$IfÖ”;Ö0ń’ó„#€$‰ €$’Ö0’’’’’’öˆ6ööÖ’’Ö’’Ö’’Ö’’2Ö 2Ö2Ö 2Ö4Öaö $$Ifa$gd:IB‘C‘Y‘c‘zqe $$Ifa$gd:I $Ifgd:I…kd¬0$$IfÖ”;Ö0ń’ó„#€$‰ €$’Ö0’’’’’’öˆ6ööÖ’’Ö’’Ö’’Ö’’2Ö 2Ö2Ö 2Ö4Öaöc‘d‘v‘€‘zqe $$Ifa$gd:I $Ifgd:I…kdv1$$IfÖ”;Ö0ń’ó„#€$‰ €$’Ö0’’’’’’öˆ6ööÖ’’Ö’’Ö’’Ö’’2Ö 2Ö2Ö 2Ö4Öaö€‘‘”‘Ŗ‘zqe $$Ifa$gd:I $Ifgd:I…kd@2$$IfÖ”;Ö0ń’ó„#€$‰ €$’Ö0’’’’’’öˆ6ööÖ’’Ö’’Ö’’Ö’’2Ö 2Ö2Ö 2Ö4ÖaöŖ‘«‘¬‘zq $Ifgd:I…kd 3$$IfÖ”;Ö0ń’ó„#€$‰ €$’Ö0’’’’’’öˆ6ööÖ’’Ö’’Ö’’Ö’’2Ö 2Ö2Ö 2Ö4Öaö¬‘­‘Ą‘ɑґ– $$Ifa$gd:I $Ifgd:IikdŌ3$$IfÖ”;Öń’„#€$ˆÖ0’’’’’’öˆ6ööÖ’Ö’Ö’Ö’2Ö 2Ö4Öaöґӑą‘ė‘ō‘^UII $$Ifa$gd:I $Ifgd:I”kdv4$$IfÖ”’ÖFń’ó„#€$‰ €$s€$ŒÖ0’’’’’’öˆ6ööÖ ’’’Ö ’’’Ö ’’’Ö ’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöґӑՑڑޑņ‘ó‘ō‘õ‘÷‘ū‘’‘ ’’’’"’#’'’+’0’=’>’@’D’G’H’U’]’_’`’b’f’z’Ž’–’˜’™’¤’„’©’Ŗ’²’¼’½’æ’Ą’Ä’Å’Ķ’×’Ų’Ś’Ū’Ż’į’÷’ł’“ “ ““““““““#“-“.“0“1“5“9“>“K“L“łģßÕßĖßÄģßÕßĖßÄģÕģßĖßÄģßģÕßĖßÄģßÕßĖßÄģÕģßĖßĖßÄģßĖßĖßÄģßÕßĖßĖßÄģßģÕßĖßĖßÄģßĖßÄ hæ(¶hq'Źhq'ŹOJQJ^Jhm1OOJQJ^Jhæ(¶hq'ŹOJQJ^Jhæ(¶h^m¼OJQJ^J hæ(¶h{ ›Mō‘õ‘’ ’’^UII $$Ifa$gd:I $Ifgd:I”kdh5$$IfÖ”’ÖFń’ó„#€$‰ €$s€$ŒÖ0’’’’’’öˆ6ööÖ ’’’Ö ’’’Ö ’’’Ö ’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaö’’(’2’=’^UII $$Ifa$gd:I $Ifgd:I”kdZ6$$IfÖ”’ÖFń’ó„#€$‰ €$s€$ŒÖ0’’’’’’öˆ6ööÖ ’’’Ö ’’’Ö ’’’Ö ’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaö=’>’J’U’_’^UII $$Ifa$gd:I $Ifgd:I”kdL7$$IfÖ”’ÖFń’ó„#€$‰ €$s€$ŒÖ0’’’’’’öˆ6ööÖ ’’’Ö ’’’Ö ’’’Ö ’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaö_’`’ƒ’Ž’˜’^UII $$Ifa$gd:I $Ifgd:I”kd>8$$IfÖ”’ÖFń’ó„#€$‰ €$s€$ŒÖ0’’’’’’öˆ6ööÖ ’’’Ö ’’’Ö ’’’Ö ’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaö˜’™’Ŗ’“’æ’^UII $$Ifa$gd:I $Ifgd:I”kd09$$IfÖ”’ÖFń’ó„#€$‰ €$s€$ŒÖ0’’’’’’öˆ6ööÖ ’’’Ö ’’’Ö ’’’Ö ’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaöæ’Ą’Å’Ļ’Ś’^UII $$Ifa$gd:I $Ifgd:I”kd":$$IfÖ”’ÖFń’ó„#€$‰ €$s€$ŒÖ0’’’’’’öˆ6ööÖ ’’’Ö ’’’Ö ’’’Ö ’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöŚ’Ū’ł’““^UII $$Ifa$gd:I $Ifgd:I”kd;$$IfÖ”’ÖFń’ó„#€$‰ €$s€$ŒÖ0’’’’’’öˆ6ööÖ ’’’Ö ’’’Ö ’’’Ö ’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaö“““%“0“^UII $$Ifa$gd:I $Ifgd:I”kd<$$IfÖ”’ÖFń’ó„#€$‰ €$s€$ŒÖ0’’’’’’öˆ6ööÖ ’’’Ö ’’’Ö ’’’Ö ’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaö0“1“6“@“K“^UII $$Ifa$gd:I $Ifgd:I”kdų<$$IfÖ”’ÖFń’ó„#€$‰ €$s€$ŒÖ0’’’’’’öˆ6ööÖ ’’’Ö ’’’Ö ’’’Ö ’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöK“L“j“u““^UII $$Ifa$gd:I $Ifgd:I”kdź=$$IfÖ”’ÖFń’ó„#€$‰ €$s€$ŒÖ0’’’’’’öˆ6ööÖ ’’’Ö ’’’Ö ’’’Ö ’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöL“N“R“h“u“}““€“„“…““—“˜“š“›“œ““µ“¶“·“æ“Ą“ȓɓϓГԓč“ī“š“ń“ņ“ś“””””””$”-”/”0”1”<”\”]”c”d”p”q”z”|”‚”„”…”†”Ž””˜”””¢”¤”„”¦”óęÜęŅęĖóęŅęŅę˾·óŖŅŖŅŖ£óęóęŅęĖęóęŅęĖęóęŅęĖęóęĖóęóęŅęŅęĖęóęŅęŅęĖę hæ(¶h{ ›hæ(¶h{ ›OJQJ^J hæ(¶hÄ4hæ(¶hÄ4OJQJ^J hæ(¶hq'Źhq'ŹOJQJ^Jhm1OOJQJ^Jhæ(¶hq'ŹOJQJ^Jhæ(¶h^m¼OJQJ^J@“€“…““š“^UII $$Ifa$gd:I $Ifgd:I”kdÜ>$$IfÖ”’ÖFń’ó„#€$‰ €$s€$ŒÖ0’’’’’’öˆ6ööÖ ’’’Ö ’’’Ö ’’’Ö ’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaöš“›“œ“^U $Ifgd:I”kdĪ?$$IfÖ”’ÖFń’ó„#€$‰ €$s€$ŒÖ0’’’’’’öˆ6ööÖ ’’’Ö ’’’Ö ’’’Ö ’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaöœ““¶“æ“Č“– $$Ifa$gd:I $Ifgd:IikdĄ@$$IfÖ”’Öń’„#€$ˆÖ0’’’’’’öˆ6ööÖ’Ö’Ö’Ö’2Ö 2Ö4ÖaöČ“É“Š“Ż“č“š“^UUII $$Ifa$gd:I $Ifgd:I”kdbA$$IfÖ”’ÖFń’ó„#€$‰ €$s€$ŒÖ0’’’’’’öˆ6ööÖ ’’’Ö ’’’Ö ’’’Ö ’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaöš“ń“ņ“ū“”@77+ $$Ifa$gd:I $Ifgd:I¾kdTB$$If4Ö”’Ö\ń’Ió„#ą$c€$& €$s€$ŒÖ0’’’’’’öˆ6ööÖ’’’’Ö’’’’Ö’’’’Ö’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaö”””””ó4++ $Ifgd:I¾kdvC$$If4Ö”’Ö\ń’Ió„# $c€$& €$s€$ŒÖ0’’’’’’öˆ6ööÖ’’’’Ö’’’’Ö’’’’Ö’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaö $$Ifa$gd:I”$”/”0”1”óó4+ $Ifgd:I¾kd˜D$$If4Ö”’Ö\ń’Ió„# $c€$& €$s€$ŒÖ0’’’’’’öˆ6ööÖ’’’’Ö’’’’Ö’’’’Ö’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaö $$Ifa$gd:I1”G”Q”\”]”öźź+¾kdŗE$$If4Ö”’Ö\ń’Ió„# $c€$& €$s€$ŒÖ0’’’’’’öˆ6ööÖ’’’’Ö’’’’Ö’’’’Ö’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaö $$Ifa$gd:I $Ifgd:I]”d”q”|”„”ööźź $$Ifa$gd:I $Ifgd:I„”…”†””š”@77+ $$Ifa$gd:I $Ifgd:I¾kdÜF$$If4Ö”’Ö\ń’Ió„#ą$c€$& €$s€$ŒÖ0’’’’’’öˆ6ööÖ’’’’Ö’’’’Ö’’’’Ö’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaö𔤔„”¦”®”ó4++ $Ifgd:I¾kdžG$$If4Ö”’Ö\ń’Ió„# $c€$& €$s€$ŒÖ0’’’’’’öˆ6ööÖ’’’’Ö’’’’Ö’’’’Ö’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaö $$Ifa$gd:I¦”­”®”¶”Ą”Į”Ć”Ä”Å”Š”Ū”ć”š”ń”ż” •••K•L•M•P•_••£•°•³•ŗ•ٕڕ – ––óęÜęÜęÕęóęÜęÕŹ»Æ • ÆŹ…ŹÆŹyŹqŹqZ,jh—m&hė<_CJUaJmHnHtHuh{ ›CJaJhÄ4h{ ›CJ\aJh-CJaJhBnĮmH sH hBnĮhBnĮCJaJhBnĮhBnĮCJaJmH sH h{ ›CJaJmH sH hŪk¹h{ ›CJaJmH sH hŪk¹h{ ›CJaJ hæ(¶hq'Źhq'ŹOJQJ^Jhæ(¶hq'ŹOJQJ^Jhæ(¶h^m¼OJQJ^J ®”ø”ÔĔŔóó4ó¾kd I$$If4Ö”’Ö\ń’Ió„# $c€$& €$s€$ŒÖ0’’’’’’öˆ6ööÖ’’’’Ö’’’’Ö’’’’Ö’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaö $$Ifa$gd:IÅ”Ū”å”š”ń”öźź+¾kdBJ$$If4Ö”’Ö\ń’Ió„# $c€$& €$s€$ŒÖ0’’’’’’öˆ6ööÖ’’’’Ö’’’’Ö’’’’Ö’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Öaö $$Ifa$gd:I $Ifgd:Iń” –,–H—g—2˜<˜G˜P˜d˜o˜ōōéįįÕÕÕÕÉ $$Ifa$gd«sĮ $$Ifa$gd¦żdągdI~ $dąa$gd[  $dąa$gdų|R –(–)–*–+–,–-–7–8–G–X–Y–n–p–{–}–†–ˆ–‹–Æ–ķŲĮŖŸ”ƒvƒeWM@M@MWe3hč8%h{ ›OJQJ^JhHdŒhBnĮOJQJ^JhBnĮOJQJ^JhBnĮOJQJ^JmH sH  hč8%h{ ›OJQJ^JmH sH hŪk¹h{ ›OJQJ^J hŪk¹h{ ›OJQJ^JmH sH hŪk¹h{ ›mH sH hŪk¹hė<_CJaJ,jh—m&hė<_CJUaJmHnHtHu,jdKh—m&hDr*CJUaJmHnHtHu)jϳ‡M hDr*OJQJUV^JnHtH#h—m&hė<_CJaJmHnHtHuƖ°–¹–ŗ–Ž–ź–ķ–ī–õ–——F—G—H—I—c—d—e—f—h—i—öéöéŲé˽˳¦Ė•‡}fU‡KAhvQOJQJ^JhI~OJQJ^J!jGTh-h-OJQJU^J-j¾³‡M h-CJUVaJmHnHsHtHhwE¾OJQJ^JjhwE¾OJQJU^J hHdŒh{ ›OJQJ^JmH sH h Vh{ ›OJQJ^Jh{ ›OJQJ^JhÄ4h{ ›OJQJ\^JhŪk¹h{ ›OJQJ^J hč8%h{ ›OJQJ^JmH sH hč8%h{ ›OJQJ^Jh-OJQJ^Ji—q—r—‡—‘—¶—¹—ŗ—č—ń—˜˜ ˜(˜)˜0˜1˜2˜G˜H˜I˜ļįŠįŠįĀį°įŸ‘įŸļƒļv_G/ j2h«sĮh¦ż6H*OJQJ]^JmH sH , jch«sĮh¦ż6OJQJ]^JmH sH h«sĮh¦żOJQJ^Jh{ ›OJQJ^JmH sH hVBFOJQJ^JmH sH  hŪk¹hVBFOJQJ^JmH sH #h h 6OJQJ^JmH sH hÉIõOJQJ^JmH sH  hŪk¹h«sĮOJQJ^JmH sH h«sĮOJQJ^JmH sH  hŪk¹h{ ›OJQJ^JmH sH I˜J˜K˜O˜P˜c˜d˜o˜p˜”˜„˜Ø˜©˜Æ˜°˜±˜²˜ø˜¹˜ó˜ō˜’˜™™™ ™ ™ ™™™™™™ ™!™źÖŵ؛؛صؑؑ؛؛€r€r€›€eXeXe€›€eh«sĮhvQOJQJ^Jh«sĮh¾3OJQJ^Jh«sĮB*OJQJ^Jph!h«sĮh¾3B*OJQJ^Jphh«sĮOJQJ^Jh«sĮh«sĮOJQJ^Jh«sĮh¦żOJQJ^Jh«sĮh¦ż6OJQJ]^J h«sĮh¦żOJQJ^JmH sH & j h«sĮh¦żOJQJ^JmH sH )h«sĮh¦ż6H*OJQJ]^JmH sH "o˜p˜q˜w˜€˜‰˜•˜”˜PDDDDDD $$Ifa$gd¦ż®kd½\$$If”Ö\ļ’÷[={"€"€"’’’’€"’’’’€"’’’’ t ö6ööÖ’’’’Ö’’’’’’’’’’’’’Ö’’’’Ö’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ(’’’’’’’’”˜£˜„˜Ø˜±˜²˜³˜ø˜¹˜Ä˜Ļ˜Ö˜Ų˜Ū˜óóóóīóóxxxóó $Ifgd¦żlkd‡b$$If”’Ö0ļ’÷{"€"’’’’€"’’’’’’’’ t ö6ööÖ’’’’’’’’Ö’’’’’Ö’’Ö’’2Ö 2Ö2Ö 2Ö4ÖaöpÖ’’’’Ffį_ $$Ifa$gd¦ż ۘߘą˜į˜ē˜ķ˜ó˜™™™™™ ™™™™™™™™™™ ™%™+™,™-™óóóóóóóīåóóóóóóóóąåóóóóóóóFfej $Ifgd¦żFfĀe $$Ifa$gd¦ż!™"™'™(™+™.™/™6™7™8™=™>™A™D™E™F™V™W™v™w™‹™„™¦™±™²™³™“™µ™½™æ™Ą™Å™Ę™É™Ģ™Ķ™Ī™Ö™Ų™Ł™Ž™ß™ā™å™ę™ē™ī™š™ń™ö™÷™ś™ż™ž™’™šš/š0šDš^š_šjškšlšmšnšvšxšóęóęÕČÕęóęóęÕČęÕČ»ČęÕ­Õ­ÕČęÕęóęóęÕČęÕęóęóęÕČęÕęóęóęÕČęÕČ»ČęÕ­Õ­ÕČęÕęh«sĮB*OJQJ^Jphh«sĮh¦żOJQJ^Jh«sĮh«sĮOJQJ^J!h«sĮh¾3B*OJQJ^Jphh«sĮh¾3OJQJ^Jh«sĮhvQOJQJ^JD-™.™/™0™2™4™6™;™A™B™C™D™E™F™J™M™Q™R™S™T™U™V™W™X™v™óīåóóóóóóóóąåóóóóóóóóŪåóFf6wFfs $Ifgd¦żFf“n $$Ifa$gd¦żv™w™„™‹™™™‘™’™“™™™Ÿ™„™³™“™’‰‰}}}}}}}}}xFfĘ| $$Ifa$gd¦ż $Ifgd¦żlkd‹y$$If”’Ö0ļ’÷{"€"’’’’€"’’’’’’’’ t ö6ööÖ’’’’’’’’Ö’’’’’Ö’’Ö’’2Ö 2Ö2Ö 2Ö4ÖaöpÖ’’’’ “™µ™·™ŗ™½™Ć™É™Ź™Ė™Ģ™Ķ™Ī™Š™Ó™Ö™Ü™ā™ć™ä™å™ę™ē™é™ė™ī™ō™ś™öźźźźźźźźåöźźźźźźźźąöźźźźźFfø…Ffi $$Ifa$gd¦ż $Ifgd¦żś™ū™ü™ż™ž™’™šš š š š ššššš/šóóóīåóóóóóóóóąåóFf:Ž $Ifgd¦żFfŠ $$Ifa$gd¦ż/š0š=šDšFšHšJšKšLšRšXš^šlšm𒉉}}}}}}}}}xFfŹ“ $$Ifa$gd¦ż $Ifgd¦żlkd$$If”’Ö0ļ’÷{"€"’’’’€"’’’’’’’’ t ö6ööÖ’’’’’’’’Ö’’’’’Ö’’Ö’’2Ö 2Ö2Ö 2Ö4ÖaöpÖ’’’’ mšnšpšsšvš|š‚šƒš„š…š†š‡š‰šŒšš•š›šœššžšŸš š¢š„šØš®š“šöźźźźźźźźåöźźźźźźźźąöźźźźźFf¼œFfm˜ $$Ifa$gd¦ż $Ifgd¦żxšyš~šš‚š…š†š‡šš‘š’š—š˜š›šžšŸš šØšŖš«š°š±š“š·šøš¹šÉšŹšŠšŃšåš’š› › › ››››››› ›#›&›'›(›0›2›3›8›9›<›?›@›A›H›J›K›P›Q›T›W›X›Y›i›j›x›y›óęóęÕČęÕęóęóęÕČęÕęóęóęÕČęÕČ»ČęÕ­Õ­ÕČęÕęóęóęÕČęÕęóęóęÕČęÕęóęóęÕČęÕČ»Čh«sĮB*OJQJ^Jphh«sĮh¦żOJQJ^Jh«sĮh«sĮOJQJ^J!h«sĮh¾3B*OJQJ^Jphh«sĮh¾3OJQJ^Jh«sĮhvQOJQJ^JD“šµš¶š·šøš¹š½šĮšÄšÅšĘšĒšČšÉšŹšĖšŠšóóóīåóóóóóóóóąåóFf>„ $Ifgd¦żFf ” $$Ifa$gd¦żКњޚåšēšéšėšģšķšóšłš’š ››’‰‰}}}}}}}}}xFfĪŖ $$Ifa$gd¦ż $Ifgd¦żlkd“§$$If”’Ö0ļ’÷{"€"’’’’€"’’’’’’’’ t ö6ööÖ’’’’’’’’Ö’’’’’Ö’’Ö’’2Ö 2Ö2Ö 2Ö4ÖaöpÖ’’’’ ››››››#›$›%›&›'›(›*›-›0›6›<›=›>›?›@›A›C›F›H›N›T›öźźźźźźźźåöźźźźźźźźąöźźźźźFfĄ³FfqÆ $$Ifa$gd¦ż $Ifgd¦żT›U›V›W›X›Y›]›a›d›e›f›g›h›i›j›k›x›óóóīåóóóóóóóóąåóFfB¼ $Ifgd¦żFfø $$Ifa$gd¦żx›y›‚›‰›‹›››‘›’›˜›ž›¤›²›³›’‰‰}}}}}}}}}xFfŅĮ $$Ifa$gd¦ż $Ifgd¦żlkd—¾$$If”’Ö0ļ’÷{"€"’’’’€"’’’’’’’’ t ö6ööÖ’’’’’’’’Ö’’’’’Ö’’Ö’’2Ö 2Ö2Ö 2Ö4ÖaöpÖ’’’’ y›‰›¤›„›°›±›²›³›“›¼›¾›æ›Ä›Å›Č›Ė›Ģ›Ķ›Ō›Ö›×›Ż›Ž›į›ä›å›ę›ķ›ī›ļ›õ›ö›ł›ü›ż›ž›œœœœ9œBœ—œžœóāŌāŌāĒóāóŗóŗóāĒóāóŗóŗóāĒóāóŗóŗóāĒóāDZŖ™…™p)h 60hq'ŹB*OJQJ^JnHphtH&h h 6OJQJ]^JmH sH  hŪk¹h{ ›OJQJ^JmH sH  hŪk¹h{ ›h«sĮhlŃCJh«sĮhvQOJQJ^Jh«sĮh«sĮOJQJ^Jh«sĮB*OJQJ^Jph!h«sĮh¾3B*OJQJ^Jphh«sĮh¾3OJQJ^J+³›“›¶›¹›¼›Ā›Č›É›Ź›Ė›Ģ›Ķ›Ļ›Ń›Ō›Ś›į›ā›ć›ä›å›ę›č›ź›ķ›ņ›ł›öźźźźźźźźåźźźźźźźźźąźźźźźźFfÄŹFfuĘ $$Ifa$gd¦ż $Ifgd¦żł›ś›ū›ü›ż›ž›œœ œ œ œ œ œœœ—œŸœ³œ»œŁœóóóīóóóóóóóóóéŽŅŅŅŅ $$Ifa$gdq'Ź $dąa$gd eåFfFÓFfĻ $$Ifa$gd¦żžœŸœ±œ²œ³œ“œµœ¶œŗœ»œäĻ“ä—vXB(3h 60hq'Ź6B*OJQJ]mHnHphsHtH+hq'ŹB*OJQJ^JmH nHphsH tH:h 60hq'Ź6B*H*OJQJ]^JmH nHphsH tH@ j2h 60hq'Ź6B*H*OJQJ]^JmH nHphsH tH9 jch 60hq'Ź6B*OJQJ]mH nHphsH tH4h 60hq'ŹB*CJH*OJQJ^JaJnHphtH)h 60hq'ŹB*OJQJ^JnHphtH5h 60hq'ŹB*CJOJQJaJmHnHphsHtH »œ¼œŲœŁœŚœŪœÜœŻœŽœßœąœįœāœćœåœęœēœčœźœėœģœņœóœōœõœöœ÷œē̳ ³‹³‹³‹³‹³‹³sW‹³E‹E³sW #hŌPÄB*OJQJ^JnHphtH7h 60hq'Ź6B*OJQJ]^JmHnHphsHtH/h 60hq'Ź6B*OJQJ]^JnHphtH)h 60hq'ŹB*OJQJ^JnHphtH$h 60hq'ŹCJaJmHnHsHtH1h 60hq'ŹB*OJQJ^JmHnHphsHtH5h 60hq'ŹB*KHOJQJ^JmH nHphsH tH/hq'ŹB*KHOJQJ^JmH nHphsH tHٜڜۜݜߜįœćœE99999 $$Ifa$gdq'ʹkd›Õ$$If–l4Ö”“Ö\”’ `ĻŻ#ą$€€Ł€$ t Ö0’’’’’’öˆ6ööÖ’’’’Ö’’’’Ö’’’’Ö’’’’4Ö4Ö laöpÖ(’’’’’’’’ćœęœčœėœōœöœ÷œüœ  *01279;=?AóóóóóīāóóóóóóóóóóŻóóóóóóóFf!Ü $$Ifa$gdŪcFfŲ $$Ifa$gdq'Ź÷œūœüœ    ()*+,/0126789:;<=>?@DEHźÕź¼ź¼ź¼ź¼ź¼ź¼£¼ź¼‘ꑼźź¼l¼ź¼ź¼ź¼ź¼ź¼ź¼lź$h 60hŪcCJaJmHnHsHtH#hŪcB*OJQJ^JnHphtH#hŌPÄB*OJQJ^JnHphtH1h 60hŪcB*OJQJ^JmH nHphsH tH1h 60hŪcB*OJQJ^JmHnHphsHtH)hŪchŪcB*OJQJ^JnHphtH)h 60hŪcB*OJQJ^JnHphtH*ABCDEINQTWZ\bhv|}~ƒ…ˆ‹Ž‘’óóóīāóóóóóóóóóóŻóóóóóóóóóFf}ä $$Ifa$gdŪcFfOą $$Ifa$gdq'ŹHIMNPQSTVWYZ[\abghituvwx{|}~‚ƒ„…‡ˆŠ‹źÕ¼Õ¼Õ¼Õ¼Õ¼Õ¼¦¼Õ¼”Õ”¼Õ‚Õ¼oZÕ¼Õ¼Õ¼Õ¼(hāĀhŪcOJQJ^JmHnHsHtH$h 60hŪcCJaJmHnHsHtH#hŪcB*OJQJ^JnHphtH#hŌPÄB*OJQJ^JnHphtH+hŪcB*OJQJ^JmHnHphsHtH1h 60hŪcB*OJQJ^JmHnHphsHtH)h 60hŪcB*OJQJ^JnHphtH)hŪchŪcB*OJQJ^JnHphtH#‹Ž“”—˜œŸ ¢£„¦Ø©Ŗ«°±¶·øĆÄÅĘĒÉŹĖĢĶŃŅŌÕ×ŲŚŪŻŽßćäēčģźŃźŃ¾źŃźŃźŃźŃźŃźŃźŃ„Ѽѓź“ŃźźŃ¾ŃźŃźŃźŃźŃźŃźŃ¾źŃź#hŪcB*OJQJ^JnHphtH#hŌPÄB*OJQJ^JnHphtH1h 60hŪcB*OJQJ^JmH nHphsH tH$h 60hŪcCJaJmHnHsHtH1h 60hŪcB*OJQJ^JmHnHphsHtH)h 60hŪcB*OJQJ^JnHphtH2’“”˜ £¦©«±·ÅĖĢĶŅÕŲŪŽąįāćäčóīóóóóóóóóóóóéóóóóóóóóóóäóFfńFfŁģFf«č $$Ifa$gdq'Źčķšóöłūžžžžžž"ž%ž'ž*ž-ž/ž0ž1ž2ž3ž7ž<ž?žBžEžóóóóóóóóóóīóóóóóóóóóóéóóóóóFfcłFf5õ $$Ifa$gdq'Źģķļšņóõöųłśūžžžžžžžžžžžžžž!ž"ž$ž%ž&ž'ž)ž*ž,ž-ž.ž2ž3ž6ž7ž;ž<ž>ž?žAžBžDžEžGžHžęŃęŃęŃęŃęŃęøęŃę¦Ń¦ęєŃęęŃęŃęŃęŃęŃęŃęŃęŃęŃęŃęŃęŃę$h 60hŪcCJaJmHnHsHtH#hŪcB*OJQJ^JnHphtH#hŌPÄB*OJQJ^JnHphtH1h 60hŪcB*OJQJ^JmH nHphsH tH)h 60hŪcB*OJQJ^JnHphtH1h 60hŪcB*OJQJ^JmHnHphsHtH2EžHžJžPžVždžjžkžlžqžtžvžyž|ž~žž€žž‚ž†ž‹žŽž‘ž”ž—ž™žŸž„žóóóóóóīóóóóóóóóóóéóóóóóóóóóFfæFf‘ż $$Ifa$gdq'ŹHžIžJžOžPžUžVžWžbžcždžežfžižjžkžlžpžqžsžtžužvžxžyž{ž|ž}žž‚ž…ž†žŠž‹žžŽžž‘ž“ž”ž–ž—ž˜ž™žžžŸž¤ž„ž¦ž±ž²žźŃøŃźŃ¦ź¦Ńź”źŃŃźŃźŃźŃźŃźŃźŃźŃźŃźŃźŃźŃźŃźŃøŃźŃ¦ź¦$h 60hŪcCJaJmHnHsHtH#hŪcB*OJQJ^JnHphtH#hŌPÄB*OJQJ^JnHphtH1h 60hŪcB*OJQJ^JmH nHphsH tH1h 60hŪcB*OJQJ^JmHnHphsHtH)h 60hŪcB*OJQJ^JnHphtH2„ž³ž¹žŗž»žĄžĆžĘžÉžĢžĻžŠžŃžŅžÓž×žÜžßžįžäžēžéžļžõžŸ Ÿ ŸóóīóóóóóóóóóóéóóóóóóóóóóóäFfIFf Ffķ $$Ifa$gdq'ʲž³ž“žµžøž¹žŗž»žæžĄžĀžĆžÅžĘžČžÉžĖžĢžĪžŅžÓžÖž×žŪžÜžŽžßžąžįžćžäžęžēžčžéžīžļžōžõžöžŸŸŸŸŸŸ Ÿ Ÿ ŸŸŸęŃæŃę¬ęŃęŃęŃęŃęŃęŃę¬ŃęŃęŃęŃęŃęŃęŃę“ęŃęŃęŃæŃę¬ęŃę#hŌPÄB*OJQJ^JnHphtH1h 60hŪcB*OJQJ^JmH nHphsH tH$h 60hŪcCJaJmHnHsHtH#hŪcB*OJQJ^JnHphtH)h 60hŪcB*OJQJ^JnHphtH1h 60hŪcB*OJQJ^JmHnHphsHtH2 Ÿ ŸŸŸŸŸŸŸ Ÿ!Ÿ"Ÿ#Ÿ'Ÿ,Ÿ/Ÿ2Ÿ5Ÿ7Ÿ9Ÿ?ŸEŸSŸYŸZŸ[Ÿ`ŸcŸfŸóóóóóóóóóóīóóóóóóóóóóóéóóóóFf„Ffw $$Ifa$gdq'ŹŸŸŸŸŸŸŸŸŸŸ"Ÿ#Ÿ&Ÿ'Ÿ+Ÿ,Ÿ.Ÿ/Ÿ1Ÿ2Ÿ4Ÿ5Ÿ6Ÿ7Ÿ8Ÿ9Ÿ>Ÿ?ŸDŸEŸFŸQŸRŸSŸTŸUŸXŸYŸZŸ[Ÿ_Ÿ`ŸbŸcŸeŸfŸhŸiŸkŸlŸmŸźŃźŃźŃźŃźŃ¾źŃźŃźŃźŃźŃźŃźŃ„Ѽѓź“ŃźźŃ¾ŃźŃźŃźŃźŃźŃź#hŪcB*OJQJ^JnHphtH#hŌPÄB*OJQJ^JnHphtH1h 60hŪcB*OJQJ^JmH nHphsH tH$h 60hŪcCJaJmHnHsHtH1h 60hŪcB*OJQJ^JmHnHphsHtH)h 60hŪcB*OJQJ^JnHphtH2fŸiŸlŸnŸoŸpŸqŸrŸvŸ{Ÿ~ŸŸ„Ÿ‡Ÿ‰ŸŸ•Ÿ£Ÿ©ŸŖŸ«Ÿ°Ÿ³Ÿ¶Ÿ¹Ÿ¼Ÿ¾ŸæŸóóóóóóīóóóóóóóóóóóéóóóóóóóóFfFfÓ $$Ifa$gdq'ŹmŸqŸrŸuŸvŸzŸ{Ÿ}Ÿ~Ÿ€ŸŸƒŸ„Ÿ†Ÿ‡ŸˆŸ‰ŸŽŸŸ”Ÿ•Ÿ–Ÿ”Ÿ¢Ÿ£Ÿ¤Ÿ„ŸØŸ©ŸŖŸ«ŸÆŸ°Ÿ²Ÿ³ŸµŸ¶ŸøŸ¹Ÿ»Ÿ¼Ÿ½ŸĮŸĀŸÅŸĘŸŹŸĖŸĶŸĪŸŠŸęÓ¾ę¾ę¾ę¾ę¾ę¾ę¾ę„ę¾ę“¾“澁¾ęÓę¾ę¾ę¾ę¾ę¾ę¾ęÓ¾ę¾ę¾ę¾#hŪcB*OJQJ^JnHphtH#hŌPÄB*OJQJ^JnHphtH1h 60hŪcB*OJQJ^JmH nHphsH tH)h 60hŪcB*OJQJ^JnHphtH$h 60hŪcCJaJmHnHsHtH1h 60hŪcB*OJQJ^JmHnHphsHtH2æŸĄŸĮŸĀŸĘŸĖŸĪŸŃŸŌŸ×ŸŁŸßŸåŸóŸłŸśŸūŸ            óóīóóóóóóóóóóóéóóóóóóóóóóäFf‹+Ff]'Ff/# $$Ifa$gdq'ŹПџӟԟ֟ן؟ٟޟߟäŸåŸęŸńŸņŸóŸōŸõŸųŸłŸśŸūŸ’Ÿ                        ! # $ & ' ( ) . / ęŃęŃęŃęøęŃę¦Ń¦ęєŃęęŃęŃęŃęŃęŃęŃęŃęŃęŃęŃęŃęŃęŃęøę$h 60hŪcCJaJmHnHsHtH#hŪcB*OJQJ^JnHphtH#hŌPÄB*OJQJ^JnHphtH1h 60hŪcB*OJQJ^JmH nHphsH tH)h 60hŪcB*OJQJ^JnHphtH1h 60hŪcB*OJQJ^JmHnHphsHtH2    ! $ ' ) / 5 C I J K P S V Y \ ^ _ ` a b f k n q óóóóóóóóóóóīóóóóóóóóóóéóóóóFfē3Ff¹/ $$Ifa$gdq'Ź/ 4 5 6 A B C D E H I J K O P R S U V X Y [ \ ] a b e f j k m n p q s t v w x y ~  „ … † ‘ ’ “ ” • ˜ źŃæźæŃź­źŃšŃźŃźŃźŃźŃźŃźŃšźŃźŃźŃźŃźŃźŃźŃŃźŃæźæŃź­ź1h 60hŪcB*OJQJ^JmH nHphsH tH$h 60hŪcCJaJmHnHsHtH#hŪcB*OJQJ^JnHphtH#hŌPÄB*OJQJ^JnHphtH1h 60hŪcB*OJQJ^JmHnHphsHtH)h 60hŪcB*OJQJ^JnHphtH2q t w y  … “ ™ š ›   £ ¦ © ¬ ® Æ ° ± ² Ī Ń Ō × Ś Ż Ž óóóóóóóīóóóóóóóóóóéóóóóóóóFfC<Ff8 $$Ifa$gdq'Ź˜ ™ š › Ÿ   ¢ £ „ ¦ Ø © « ¬ ­ ± ² Ę Ź Ķ Ī Š Ń Ó Ō Ö × Ł Ś Ü Ž ß ęÓę¾ę¾ę¾ę¾ę¾ę¾ęÓ¬š…l…l…l…l…l…lY$h 60hq'ŹCJaJmHnHsHtH1h 60hq'ŹB*OJQJ^JmHnHphsHtH)h 60hq'ŹB*OJQJ^JnHphtH#hÉIõB*OJQJ^JnHphtH#hŪcB*OJQJ^JnHphtH)h 60hŪcB*OJQJ^JnHphtH$h 60hŪcCJaJmHnHsHtH1h 60hŪcB*OJQJ^JmHnHphsHtHŽ ß D”[”.¢£<£b£¤£Ø£Ŗ£®£°£“£¶£ŗ£¼£Ō£Ö£Ų£Ś£Ü£śņēÜÜÜÜŃĻĻĻĻĻĻĻĻČĀĻĻŃ„h]„h„ų’„&` $dąa$gdWŗ $dąa$gd“Z $dąa$gd eådągd eåFfō?ß ą ”%”;”<”C”D”E”¢,¢.¢n¢¤¢Ī¢Š¢£££:£<£éŌæŖ˜Ŗ˜‡se‡e‡e‡WF5F5 hŪz]h{ ›OJQJ^JmHsH h°Vh{ ›OJQJ^JmHsHh‚{1OJQJ^JmHsHh‚{1OJQJ^JmH sH &hŪk¹h{ ›5OJQJ\^JmH sH  hŪk¹h{ ›OJQJ^JmH sH "h{ ›CJOJQJ^JaJmH sH (h»āh{ ›CJOJQJ^JaJmH sH (h°Vh{ ›CJOJQJ^JaJmHsH(h»āh{ ›CJOJQJ^JaJmHsH+h»āh{ ›CJH*OJQJ^JaJmHsH<£¤£¦£Ø£Ŗ£¬£®£°£²£“£¶£ø£ŗ£¼£¾£Ź£Ģ£Š£Ņ£Ō£Ö£Ų£Ś£Ü£ļćŪ×ćŪ×ćŪ×ćŪ×ÉæÉ°ÉæØ¤×ļh}üh}üCJaJh*0JCJaJmHnHuh}ü0JCJaJjh}ü0JCJUaJhmīhmīCJaJjhmīCJUaJ hŪk¹h{ ›OJQJ^JmH sH >&P 1hP:p.JBP°ƒ. °ĒA!°‰"°‰#‰$‰%°°Å°Å ÄDŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© žhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Strnad%20M%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlusyXō;HÆ,‚]ą'c„«DŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© ¢http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Presecki%20V%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlusyXō;HÆ,‚]ą'c„« DŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© œhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Babus%20V%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlusyXō;HÆ,‚]ą'c„« DŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© œhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Turek%20S%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlusyXō;HÆ,‚]ą'c„«DŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK©  http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Dominis%20M%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlusyXō;HÆ,‚]ą'c„«DŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© Ŗhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Kaleni%C4%87%20S%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlusyXō;HÆ,‚]ą'c„«ėDŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© zjavascript:AL_get(this, 'jour', 'Lijec Vjesn.');yXō;HÆ,‚]ą'c„«½DŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© Lhttp://www.ncbi.nlm.nih.gov/pubmed/15495287?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSumyXō;HÆ,‚]ą'c„«DŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© žhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Tentor%20D%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlusyXō;HÆ,‚]ą'c„«DŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK©  http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Ziegler%20H%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlusyXō;HÆ,‚]ą'c„« DŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© šhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Dhom%20G%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlusyXō;HÆ,‚]ą'c„«ƒDŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Dixon+MF%22%5BAuthor%5DyXō;HÆ,‚]ą'c„«ƒDŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Genta+RM%22%5BAuthor%5DyXō;HÆ,‚]ą'c„«‡DŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Yardley+JH%22%5BAuthor%5DyXō;HÆ,‚]ą'c„«ƒDŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Correa+P%22%5BAuthor%5DyXō;HÆ,‚]ą'c„«ēDŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© vhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Loffeld%20RJ%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlusyXō;HÆ,‚]ą'c„«ķDŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© |http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Werdmuller%20BF%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlusyXō;HÆ,‚]ą'c„«ēDŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© vhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Kusters%20JG%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlusyXō;HÆ,‚]ą'c„«ēDŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© vhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Kuipers%20EJ%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlusyXō;HÆ,‚]ą'c„«’DŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© Žjavascript:AL_get(this, 'jour', 'Scand J Gastroenterol.');yXō;HÆ,‚]ą'c„«DŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© ¤http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Vorobjova%20T%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlusyXō;HÆ,‚]ą'c„«DŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© ¢http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Maaroos%20HI%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlusyXō;HÆ,‚]ą'c„« DŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© šhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Uibo%20R%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlusyXō;HÆ,‚]ą'c„«ßDŠÉźyłŗĪŒ‚ŖK© ąÉźyłŗĪŒ‚ŖK© njavascript:AL_get(this, 'jour', 'APMIS.');yXō;HÆ,‚]ą'c„«Č$$If–ń’!vh5Ö5Ö‘#v#v‘:V ”’Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ö’9Ö2Ö 2Ö2Ö 2Ö4Ö aöš$$If–ń’!vh5ÖX5ÖŖ5Ö‘#vX#vŖ#v‘:V ”’Ö0’’’’’’öˆ6ö,Ö5Öc5Ö& 5Ö’9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aöš$$If–ń’!vh5ÖX5ÖŖ5Ö‘#vX#vŖ#v‘:V ”’Ö0’’’’’’öˆ6ö,Ö5Öc5Ö& 5Ö’9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aöš$$If–ń’!vh5ÖX5ÖŖ5Ö‘#vX#vŖ#v‘:V ”’Ö0’’’’’’öˆ6ö,Ö5Öc5Ö& 5Ö’9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aö $$If–ń’!vh5Ö“##v“#:V ”’Ö0’’’’’’öˆ6ö,Ö5Öˆ9Ö2Ö 2Ö4Ö aö $$If–ń’!vh5Ö“##v“#:V ”’Ö0’’’’’’öˆ6ö,Ö5Öˆ9Ö2Ö 2Ö4Ö aöČ$$If–ń’!vh5Ö5Ö‘#v#v‘:V ”;Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ö’9Ö2Ö 2Ö2Ö 2Ö4Ö aöČ$$If–ń’!vh5Ö5Ö‘#v#v‘:V ”;Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ö’9Ö2Ö 2Ö2Ö 2Ö4Ö aöČ$$If–ń’!vh5Ö5Ö‘#v#v‘:V ”;Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ö’9Ö2Ö 2Ö2Ö 2Ö4Ö aöČ$$If–ń’!vh5Ö5Ö‘#v#v‘:V ”;Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ö’9Ö2Ö 2Ö2Ö 2Ö4Ö aöČ$$If–ń’!vh5Ö5Ö‘#v#v‘:V ”;Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ö’9Ö2Ö 2Ö2Ö 2Ö4Ö aö $$If–ń’!vh5Ö“##v“#:V ”;Ö0’’’’’’öˆ6ö,Ö5Öˆ9Ö2Ö 2Ö4Ö aöš$$If–ń’!vh5Ö5Ö5Öv#v#v#vv:V ”’Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aöš$$If–ń’!vh5Ö5Ö5Öv#v#v#vv:V ”’Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aöš$$If–ń’!vh5Ö5Ö5Öv#v#v#vv:V ”’Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aöš$$If–ń’!vh5Ö5Ö5Öv#v#v#vv:V ”’Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aöš$$If–ń’!vh5Ö5Ö5Öv#v#v#vv:V ”’Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aöš$$If–ń’!vh5Ö5Ö5Öv#v#v#vv:V ”’Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aöš$$If–ń’!vh5Ö5Ö5Öv#v#v#vv:V ”’Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aöš$$If–ń’!vh5Ö5Ö5Öv#v#v#vv:V ”’Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aöš$$If–ń’!vh5Ö5Ö5Öv#v#v#vv:V ”’Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aöš$$If–ń’!vh5Ö5Ö5Öv#v#v#vv:V ”’Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aöš$$If–ń’!vh5Ö5Ö5Öv#v#v#vv:V ”’Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aöš$$If–ń’!vh5Ö5Ö5Öv#v#v#vv:V ”’Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aöš$$If–ń’!vh5Ö5Ö5Öv#v#v#vv:V ”’Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aö $$If–ń’!vh5Ö“##v“#:V ”’Ö0’’’’’’öˆ6ö,Ö5Öˆ9Ö2Ö 2Ö4Ö aöš$$If–ń’!vh5Ö5Ö5Öv#v#v#vv:V ”’Ö0’’’’’’öˆ6ö,Ö5Ö‰ 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aö $$If–ń’!vh5ÖX5ÖŖ5Ö5Öv#vX#vŖ#v#vv:V 4”’Ö0’’’’’’öˆ6ö+Ö,Ö5Öc5Ö& 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aö $$If–ń’!vh5ÖX5ÖŖ5Ö5Öv#vX#vŖ#v#vv:V 4”’Ö0’’’’’’öˆ6ö+Ö,Ö5Öc5Ö& 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aö $$If–ń’!vh5ÖX5ÖŖ5Ö5Öv#vX#vŖ#v#vv:V 4”’Ö0’’’’’’öˆ6ö+Ö,Ö5Öc5Ö& 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aö $$If–ń’!vh5ÖX5ÖŖ5Ö5Öv#vX#vŖ#v#vv:V 4”’Ö0’’’’’’öˆ6ö+Ö,Ö5Öc5Ö& 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aö $$If–ń’!vh5ÖX5ÖŖ5Ö5Öv#vX#vŖ#v#vv:V 4”’Ö0’’’’’’öˆ6ö+Ö,Ö5Öc5Ö& 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aö $$If–ń’!vh5ÖX5ÖŖ5Ö5Öv#vX#vŖ#v#vv:V 4”’Ö0’’’’’’öˆ6ö+Ö,Ö5Öc5Ö& 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aö $$If–ń’!vh5ÖX5ÖŖ5Ö5Öv#vX#vŖ#v#vv:V 4”’Ö0’’’’’’öˆ6ö+Ö,Ö5Öc5Ö& 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aö $$If–ń’!vh5ÖX5ÖŖ5Ö5Öv#vX#vŖ#v#vv:V 4”’Ö0’’’’’’öˆ6ö+Ö,Ö5Öc5Ö& 5Ös5ÖŒ9Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö aöćDd T!0ččšb² š c š$€€A?æ ’?3"ńæ`æ€  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~€‚ƒ„…†‡ˆ‰Š‹ŒŽ‘’“”•–—˜™š›œžŸ ”¢£¤„¦§Ø©Ŗ«¬­®Æ°±²³“µ¶·ø¹ŗ»¼½¾æĄĮĀĆÄÅĘĒČÉŹĖĢĶĪĻŠŃŅÓŌÕÖ×ŲŁŚŪÜŻŽž’’’ąįāćäåęēčéźėģķīļšńņóōõö÷ųłśūüżž’>ż’’’ż’’’ż’’’ 'ž’’’»  !"#$%&ž’’’3)*+,-./012ž’’’ŗ56789:;<=ž’’’?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}ż’’’€Root Entry’’’’’’’’ ĄF°Ī®°ŁøÉ Data ’’’’’’’’’’’’ßóAWordDocument’’’’’’’’@¼ObjectPool’’’’Տ°ŁøÉ°Ī®°ŁøÉ_1300739023 ’’’’ĄFՏ°ŁøÉՏ°ŁøÉOle ’’’’’’’’’’’’EPRINT’’’’ 6CompObj’’’’’’’’’’’’jž’’’ž’’’ž’’’ž’’’ž’’’ž’’’ ž’’’ž’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’ž’ ’’’’ĄFMicrosoft Graphov grafikonGBiff5MSGraph.Chart.8ō9²q ž’ ’’’’ĄFMicrosoft Graphov grafikonGBiff5MSGraph.Chart.8ō9²q l‰w˜ & Č:?5 EMF6ą˜žŹ "ĖfF, EMF+@ĄŪXXF\PEMF+"@ @ $@ 0@€?!@ @   ’’’  !" ’’’’!" ’’’’ ! ’’’ Rp­’’’ī"ArialŌäÖŽ /%ē %$åōä,ß /ē$å%J åāą /ē$å% %(å¦į /ē%čę /ē% ¼ēč"ZR$ /?.BCCCCCCCCfäå˜åqv2!09Œęģå=¼Ši2!09dv% % €% % €% % €% % €% % €% % €% % €% % €% RpÆ’’’ī"ArialŌäÖŽ /#ē #$åōä,ß /ē$å#I åāą /ē$å# #(å¦į /ē#čę /ē# ¼ēd#ZR$ /0*>>>>>>>fäå˜åqv2!09Œęģå=¼Ši2!09dv% % €% % €% % €% % €% % €% % €% % €% % €% % €" ’’’’!%  ’’’ Ś ™ % €" ’’’’!%  ’’’ Ś ™ % €" ’’’’!%  ’’’  ŗ y % €" ’’’’!%  ’’’ šĪ•  % €" ’’’’!%  ’’’ 𾤠 &% '’’’%  ’’’  V0hÓ ‹ mŲ †Ų † m mŲ V0&wI +|D|D + +|V0äx  é} }  é é}V0¢ ÕÅ  § ŚĄ ŚĄ  §  § ŚV0h§‹Ż m¬†¬†Ų mŲ m¬V0&źI+ļDļD|+|+ļV0ä? ‚éD D }é}éDV0¢ „Å ß§ ‰Ą ‰Ą ڧ ڧ ‰V0h‹±m’†’†¬m¬m’V0&Iō+DDļ+ļ+V0äā Iéē ē DéDéēV0¢ āŠާ ēĄ ēĄ ‰§ ‰§ ēV0hŹ‹—mφφ’m’mĻV0&ŹI +ĻDĻD++ĻV0äŹ ģéĻ Ļ ēéēéĻV0¢ ŹÅ ģ§ ĻĄ ĻĄ ē§ ē§ Ļ% €% €% €" ’’’’!% % %  ’’’ ’’’šĪ•  % €% €% €" ’’’’!% % %  ’’’ ’’’Ś ™ &% ( ›Ļ  6› % ‚ 6› ‚/ 6›/ ‚A 6›A ‚R6›R‚d6›d‚v6›v‚ˆ6›ˆ‚š6›š‚«6›«‚½6›½‚Ļ6›Ļ› 6“  ›6 6› Y6 6Y 6 6 Õ 6 6Õ  “ 6 6“  % €% €% €" ’’’’!% % %  ’’’ ’’’Ś ™ % €% % €% €% €" ’’’’!% % %  ’’’ ’’’Ö µ‘ B   Tdć Ėƒ &_̇@?@‡@ć ĖL’’’’’’’’T88.9...% €% % €% €% €" ’’’’!% % %  ’’’ Ś ™ % €% % €% €% €" ’’’’!% % %  ’’’ ‡ź  TlÜų_̇@?@‡@L’’’’’’’’X92.80....% €% % €% €% €" ’’’’!% % %  ’’’ Ś ™ % €% % €% €% €" ’’’’!% % %  ’’’ ³“ @A   T`ĄŹ 2% _̇@?@‡@ĄŹ L’’’’’’’’T2.9..% €% % €% €% €" ’’’’!% % %  ’’’ Ś ™ % €% % €% €% €" ’’’’!% % %  ’’’ Z†   Tdgœ÷_̇@?@‡@gœL’’’’’’’’T49.8...% €% % €% €% €" ’’’’!% % %  ’’’ Ś ™ % €% % €% €% €" ’’’’!% % %  ’’’ ķ kz ų  T`ś l Ü_̇@?@‡@ś L’’’’’’’’T3.4..% €% % €% €% €" ’’’’!% % %  ’’’ Ś ™ % €% % €% €% €" ’’’’!% % %  ’’’ ¦§  T`&0˜‹_̇@?@‡@&0L’’’’’’’’T2.4..% €% % €% €% €" ’’’’!% % %  ’’’ Ś ™ % €% % €% €% €" ’’’’!% % %  ’’’ œüW‰  Td©Im_̇@?@‡@©L’’’’’’’’T55.6...% €% % €% €% €" ’’’’!% % %  ’’’ Ś ™ % €% % €% €% €" ’’’’!% % %  ’’’ Zoü  Tdg…ą_̇@?@‡@g…L’’’’’’’’T38.2...% €% % €% €% €" ’’’’!% % %  ’’’ Ś ™ % % €% % €% €% €" ’’’’!% % %  ’’’ ō į m  T` ÷q Q_̇@?@‡@ ÷L’’’’’’’’T6.8--% €% % €% €% €" ’’’’!% % %  ’’’ Ś ™ % €% % €% €% €" ’’’’!% % %  ’’’ Ō§`  T`)ź™D_̇@?@‡@)źL’’’’’’’’T3.9--% €% % €% €% €" ’’’’!% % %  ’’’ Ś ™ % €% % €% €% €" ’’’’!% % %  ’’’ ŁUe  TdŖļGI_̇@?@‡@ŖļL’’’’’’’’T33.3---% €% % €% €% €" ’’’’!% % %  ’’’ Ś ™ % €% % €% €% €" ’’’’!% % %  ’’’ r5żĮ  T`Kļ„_̇@?@‡@KL’’’’’’’’T9.7--% €% % €% €% €" ’’’’!% % %  ’’’ Ś ™ % €% % €% €% €" ’’’’!% % %  ’’’ ī ay ķ  T`ū wk Ń_̇@?@‡@ū wL’’’’’’’’T1.0--% €% % €% €% €" ’’’’!% % %  ’’’ Ś ™ % €% % €% €% €" ’’’’!% % %  ’’’ %e°ń  T`2{¢Õ_̇@?@‡@2{L’’’’’’’’T1.0--% €% % €% €% €" ’’’’!% % %  ’’’ Ś ™ % €% % €% €% €" ’’’’!% % %  ’’’ “ź?v  T`Į1Z_̇@?@‡@ĮL’’’’’’’’T8.2--% €% % €% €% €" ’’’’!% % %  ’’’ Ś ™ % €% % €% €% €" ’’’’!% % %  ’’’ r„ż1  T`»ļ_̇@?@‡@»L’’’’’’’’T2.4--% €% % €% €% €" ’’’’!% % %  ’’’ Ś ™ % % €% €% €" ’’’’!% % %  ’’’ Ś ™   TXåķ \H _̇@?@‡@åķ L’’’’’’’’P0%.JT`·’ \Z _̇@?@‡@·’ L’’’’’’’’T10%..JT`· \l _̇@?@‡@· L’’’’’’’’T20%..JT`·"\}_̇@?@‡@·"L’’’’’’’’T30%..JT`·4\_̇@?@‡@·4L’’’’’’’’T40%..JT`·F\”_̇@?@‡@·FL’’’’’’’’T50%..JT`·X\³_̇@?@‡@·XL’’’’’’’’T60%..JT`·j\Å_̇@?@‡@·jL’’’’’’’’T70%..JT`·{\Ö_̇@?@‡@·{L’’’’’’’’T80%..JT`·\č_̇@?@‡@·L’’’’’’’’T90%..JTd‰Ÿ\ś_̇@?@‡@‰ŸL’’’’’’’’T100%...J% €% €% €" ’’’’!% % %  ’’’ Ś ™ % €% €% €" ’’’’!% % %  ’’’ Ś ™   T” d čæ _̇@?@‡@ d L’’’’’’’’dInflammation..GG...T|7d 9æ _̇@?@‡@7d L’’’’’’’’\Activity7*)'Txéd  æ _̇@?@‡@éd L’’’’’’’’\Atrophy7...'Tˆ d Ł æ _̇@?@‡@ d L’’’’’’’’`Intestinal..*..Tˆk Ė ü & _̇@?@‡@k Ė L’’’’’’’’`metaplasiaG....*.% €% €% €" ’’’’!% % %  ’’’ Ś ™ % €( % €( % €" ’’’’ Ś ™ ! ’’’ " ’’’’ ! ’’’ ( ( " ’’’’F4(EMF+*@$€?€€€?€€FEMF+@ ObjInfo ’’’’Workbook’’’’’’’’’’’’(ö_1300739006’’’’’’’’ ĄFՏ°ŁøÉՏ°ŁøÉOle ’’’’’’’’’’’’ €©ĶĮB°"#,##0\ "kn";\-#,##0\ "kn"##,##0\ "kn";[Red]\-#,##0\ "kn"$#,##0.00\ "kn";\-#,##0.00\ "kn")$#,##0.00\ "kn";[Red]\-#,##0.00\ "kn">*9_-* #,##0\ "kn"_-;\-* #,##0\ "kn"_-;_-* "-"\ "kn"_-;_-@_->)9_-* #,##0\ _k_n_-;\-* #,##0\ _k_n_-;_-* "-"\ _k_n_-;_-@_-F,A_-* #,##0.00\ "kn"_-;\-* #,##0.00\ "kn"_-;_-* "-"??\ "kn"_-;_-@_-F+A_-* #,##0.00\ _k_n_-;\-* #,##0.00\ _k_n_-;_-* "-"??\ _k_n_-;_-@_-1 ’¼īCalibri1 ’¼īCalibri1Ć’¼Calibri1@’¼īCalibri1@’¼īCalibri1Č’īArial1Ć’īArial1 ’¼īArial=ˆ’\žĶ2v/,##0.00\… €€©ĶĮ` JŖ  ` JŖ  `  ÷Č` F哬8’ā8’’’’’’’’’’’’€€€€€€€€€ĄĄĄ€€€™™’™3f’’ĢĢ’’ff’€€fĢĢĢ’€’’’’’’€€€€€’Ģ’Ģ’’Ģ’Ģ’’™™Ģ’’™ĢĢ™’’Ģ™3f’3Ģ̙̒̒™’fff™–––3f3™f333™3™3f33™333\’’’R3Œ&STU InflammationActivityAtrophyIntestinal metaplasia no change333333@fffffęH@333333W@š™™™™9V@mildeĶĢĢĢĢĢK@š™™™™C@333333@333333 @moderatefffff¦@@ffffff#@333333@333333@markedffffff @333333@š?š?WY  @8Į = 63: 4Ź>X4š©ƒ3 d‡é 3Q  no changeQQQ’’3_ O ’’’’’’  MMd 4E4 3Q mildeQQQ’’3_ O ’’’’’’  MMd 4E4 3Q moderateQQQ’’3_ O ’’’’’’  MMd 4E4 3Q markedQQQ’’3_ O ’’’’’’  MMd 4E4D$% Ś’’’Ö’’’±M3O&Q4$% Ś’’’Ö’’’±M3O&Q4FA“ ˜ Ź 3OÉN‘ 3 bļ#M&43*#M&43œ’–" ż’3_ M ’’’NM  MMd 444% m T•³…M#3O,#&Q  88.9'4% 5 ¶³…M#3O6#&Q 92.80'4% a s³…M#3O!#&Q  2.9'4% #ž •³…M#3O,#&Q  49.8'4% Ś’’’Ö’’’•M#3O&Q'’’4% { ćs³…M#3O!#&Q  3.4'4% > s³…Mš#3Oų’’’!#&Q  2.4'4% śš •³…M#3O,#&Q  55.6'4% #q•³…M#3O,#&Q  38.2'4% Ś’’’Ö’’’•M#3O&Q'’’4% € 5s³…Mš#3Oł’’’!#&Q  6.8'4% > %s³…Mš#3Oł’’’!#&Q  3.9'4% ś³•³…M#3O,#&Q  33.3'4% 2žs³…M#3O!#&Q  9.7'4% Ś’’’Ö’’’•M#3O&Q'’’4% { ‘s³…Mš#3Oź’’’!#&Q  1.0'4% H œs³…Mš#3Oü’’’ģ’’’!#&Q  1.0'4% ?s³…M#3O!#&Q  8.2'4% 2ės³…Mš#3O!#&Q  2.4'4% Ś’’’Ö’’’•M#3O&Q'’’44 CompObj ’’’’jObjInfo’’’’’’’’Workbook’’’’’’’’’’’’4Č1Table’’’’וР€©ĶĮB°"#,##0\ "kn";\-#,##0\ "kn"##,##0\ "kn";[Red]\-#,##0\ "kn"$#,##0.00\ "kn";\-#,##0.00\ "kn")$#,##0.00\ "kn";[Red]\-#,##0.00\ "kn">*9_-* #,##0\ "kn"_-;\-* #,##0\ "kn"_-;_-* "-"\ "kn"_-;_-@_->)9_-* #,##0\ _k_n_-;\-* #,##0\ _k_n_-;_-* "-"\ _k_n_-;_-@_-F,A_-* #,##0.00\ "kn"_-;\-* #,##0.00\ "kn"_-;_-* "-"??\ "kn"_-;_-@_-F+A_-* #,##0.00\ _k_n_-;\-* #,##0.00\ _k_n_-;_-* "-"??\ _k_n_-;_-@_-1 ’¼īCalibri1 ’¼īCalibri1Ć’¼Calibri1@’¼īCalibri1@’¼īCalibri1Č’īArial1Č’¼Calibri=ˆ’\žĶ2ł3,##0.00\…ę €€©ĶĮ` JŖ  ` JŖ  `   Ȭ8’ā8’’’’’’’’’’’’€€€€€€€€€ĄĄĄ€€€™™’™3f’’ĢĢ’’ff’€€fĢĢĢ’€’’’’’’€€€€€’Ģ’Ģ’’Ģ’Ģ’’™™Ģ’’™ĢĢ™’’Ģ™3f’3Ģ̙̒̒™’fff™–––3f3™f333™3™3f33™333\’’’R3Œ&STU InflammationActivityAtrophyIntestinal metaplasiaffffffž?š™™™™:@š™™™™YV@333333S@fffffę@@F@333333@333333@š™™™™™I@33333³6@333333@ĶĢĢĢĢĢ/@*@ĶĢĢĢĢĢ@ą?ffffffž?WYo o @8Į = Ė| lB >X4š©š©3 d 3QQQQ’’3_ O ’’’’’’  MMd 4E4 3QQQQ’’3_ O ’’’’’’  MMd 4E4 3QQQQ’’3_ O ’’’’’’  MMd 4E4 3QQQQ’’3_ O ’’’NM  MMd 4E4D $% Ś’’’Ś’’’±M3O&Q4$% Ś’’’Ś’’’±M3O&Q4FA™S k 3OMM3 bļ#M&43*#M&43œ’–" 44% mf s£…Mš#3Oó’’’!#&Q  1.9'4% ³š •£…M#3O,#&Q  26.1'4%  ±•£…M#3O,#&Q  89.4'4% \ ˆ•£…M#3O,#&Q  76.8'4% Ś’’’Ś’’’•M#3O&Q'’’4% ³>•£…M#3O,#&Q  44.0'4% ^, •£…M#3O,#&Q  33.8'4% k s£…M#3O!#&Q  5.3'4%  Ys£…M#3O!#&Q  5.3'4% Ś’’’Ś’’’•M#3O&Q'’’4% \ œ•£…M#3O,#&Q  15.9'4%  »s£…Mš#3O!#&Q  4.8'4% ³Å•£…M#3O,#&Q  22.7'4% ^w•£…M#3O,#&Q  51.2'4% Ś’’’Ś’’’•M#3O&Q'’’4% ĘÓs£…Mš#3O!#&Q  7.2'4% ^$•£…M#3O,#&Q  13.0'4% k is£…M#3O!#&Q  1.9'4%  s£…Mš#3Oļ’’’!#&Q  0.5'4% Ś’’’Ś’’’•M#3O&Q'’’44 ?š€"š- óćĘŽ©¢śĀNc’ ØKn@=š óćĘŽ©¢śĀNcč570hRŌžJĻžxŚķ[]lTE>³»żŁ°IUJ)H€“•R~’–VŖ\ʆŸb@,P(M7RK‹€<,Äc“bˆšōI_L ¶&$%ž§¬“±IŖ1&Äųąƒ©ēĢ=s;;ÜīĄĘ¶ÉŽĶÉüœ¹g¾¹ß̜™»sA™‹RƒÜą]kⳟ(Ł“µ@ĄX5ĄM,“ ʕƒeĀßą½OˆTÕķŪ¹Š€•(%(hn…ˆ ˜ń"”PŃ?ŃmXØģK(Ūøli,³ŲŽ‚XŌ‹—” ƌ…¤­ˆL%7,ŠåyŗH ¼ųc0œććććš(Ēg£<Āql*,BÉG)(;ī—WĄmQ—*£×”×½„CŠSų‹”Śõ¶ū ’¤*6B'$ Yņtæ×B—½Y 7nV„JĪŠĪžb Ģ€ń“˜’<ŹŹ_ +(ŸŅTf!?ā¬óFG&ōt_ ßÓÜru9œGa ¦¢=å‹ĪĆXé‹bGY“‚źĻC)ąēRč# ÅƝłõĪXWī¼—O¬˜#ā•˜·žś-²>ņV1ÄPž¹ņFB×µœ4Ą®Chql[r&櫾š‚¾sNė;ÉIśĪ¹€¾“侐ōé;IŸ¾“ŌśNĖb·ļ„y¬ēk}ČŠā™č;”I8™©ł~sš^v²¹kĻ£źZ‹…#”™c;ĀRroȤķ (›É%bįoEęm£;†\,|m/Åų|هŻKw½Ź.éžŅŚ l_/Ńüb:_ųłY”f”¬ģ<†ƒBŗĢē„ Šf)B•¢‘,\€Ŗüå’A1$QÆ|–iå9N•Æ­˜&uRZ=<}X¦Ć[Zł>эi’AŃ'„;’øų<üc˜&Ų)­ć?É8źįĒA•Ų)­ćobü­ š7aŗI¶”NJS ž6Ęß ¦Ūdś¤“„ąO0ž1Pų˜NČ64KI¤ąßÉųO‚Ā9b§la§“Ž?Īų›<üqLĒeź¤ÄSšĒ›‡?ŽéølCŸ”x ~‡ń'<ü¦نf)N ~‡ńļōšcŽpdūVžš;Œ?īįw0ķČ6ŌIqRš;Œ?īįw0ķČ6ōIq¼ń’§Ķ© ÅmĘø>ęō1ź7ö)4ÆLsnVóPNšyˆtĖ“:ęńz9ĘÜśĶ9dgVnP¤®ć”֙eu}Æ”ļ5ō§ żiCßhč }¹”/7ōł†>ߊm5ŚwÅŠ_1ō żECßač; ½cčƒ#żłŅ>Q¾¤æ–ęł_2ō— }©H՗ŠTżCĮŠžk>ųtŒˆIĘHĪ}Œ‘ 5žT`$ß÷0Ź0Źr‘ŗ7žl<6Ņŗå3LĢE¹RĘūXˆĶ®Å;j•Žš4ū‰q¾ČĪ:ü•ćJ;×š§Ė³²]NŒõxsŹ”Å"=‡“'܌‰9ä³Qž48Tŗœ4ī–ū¤UČį:éGM³\Ž?Fā§ ¼†įõ.靣1”Ė˜‘wo s©tį€ńøJŽĘģXĢĘa”½hą »Dš|ś3Ź~ĢųĆvƒ?„ šOW#{4³óif0’;®{‚Ēą—¼ßā}œĪ”ŅĮ*dpu–æŒ`$¶‹ö–¶[š×€‰=6ń>VēOélęŠ,™ĮHļ6”×1Üg1‡Ŗ5 łĢŻĘŖtAsh5žŹq'‘C3ēūĮõƒ×ĮĪ^×^…{żąeę°Jī+VĶhmŽįgśŻ ŽĻ…ūģÄš°Åœś•p’ĒżĆżŸJ4§®‘«š`.§śŁŲŒĒ©Ęčš»Īƒ²ąo+æŻĒļ‚už”ĪfM³>Ė_F0’O|\Ÿų)ŲłÄ^p}āĒpÆO쵚O‰Į*«ł4Ėa0Fņc{ŲĒuZŒĮpĒŽ]ęSēPé‚Ę ķ ×fłĖFŚ®ć}įvĖ}a ļ ·ųģ k,ų{ł«Ģņ—Œ[˜æC–üř£ż>üųüżļiÜŹ>­ģŽĻIN›ļF·[šēī(²üeŹ’Õ²’Ūké’źŁ’ķņńõ|/3]ł›nūŌtœŃ’B‹ŁOVó’:gJJĆŁ6y6c‰äi–ÖčœĮ»l÷CĆ®ŅĻŕ²ķj=kŚļdūg}ģwZż’Ž~ŪßėcæAŲģ§ŅŪ_Źö«}ģ/µ°æ:Ą>°ż‡|ģƒ…żźūĆąŚ’ īµ?lõ¾ ½ż~¶’µż~ ūkģ÷°ż÷}ģ÷XłšōöŪŲž+>öŪ¬öžö[ų[€Z¶æŻ°Æt‹ń„Ę®^Ēt|Ļ6ŻēŅw8üNøūžcĢ)ݬ4œ“ȳcķøV:ĶpĶŠ \µĖ¾’Ē}FÅÕy{å+ƏTß”øŽ}0)]~Lō}ĒF8$qœ@é‚S5źĢį0¢ÕMēŸ®}:ßgÖ­tyuwįŽūtąˆ9EēSµsĮy†4ņū–OŲöŸz•® M½˜‡.8 ĒeĖŪåéü°Ļ¹ ó¹‡5a=£(æ ÷{‡Ņį8Šŗ°öŁ'ŽĖ—…>8Ā>ńé8ŽŃNr™Ķ<-?'Ķł÷(ŸSvƒ¾ßyoō{넿uĻFŅ·NĖce^[“xŪ’ŌćõģŠųžö}Ó^Oė)žG¤FvDd 9!9!ččšb² š c š$€A?æ ’?3"ńæ`æ€?š€"šĄėĘŲÓ?E~ó÷"…®č®H’œ‹Tn@=š”ėĘŲÓ?E~ó÷"…®č®Hš5780hR§hRbžxŚķ[]lTE>³»t馢@¹®@)• ŚæķÆ©a[bČ’jéC)B‘Ņ"c‰>Ų4jxByą”y1ĘšŠC‰1D^ˆ1`H#š(šTCRĻ™{ęvvövļ€+”äŽędgī™ūĶwęģ9÷Ģö^»Q–££TE*PŌŃ“ ą”Ļ„;ÜhøśĒ<ųF8"SuõjģŁ€§PV  ÜZ‘Ąv)J¤tāŗl+ ķAéā±+S1(a¼e©Bƽ 1T»6‘X.·Ńu婸§‹„Ąk—ĮL{)·§§§įQn/@YČmZŠr”ł(+gĘNū+b[Ō”ĘčsčsæŒ2$hUn‘R;Žŗkų;MŃ{”z„Ÿīī(ƒS«Kjä:|ņ:œž¹ .]P3ū‰ke°źÖŁø®ō΃֟Ąė¾¼¹¤fžoīłŚśõ[č3…ć–kćŌ5‡~)ƒĻßńÕĢ|ēź7 2ļž»‚×Ņł8¬—öĆ6iķ)žĪŽøĖÖõkDG_”gūöK7@%Æ½ŠŚčėŃš|x><Ÿ}Ž/ßécgĖkĖ8ĒŖ£9āŹƒ‚cIF\É'ö ɔ葒öų\Ä1cäÓČĢų‹b ū$S⢠ĖąŸfž×=ži䞖6 HIgš—’ˆĒū$#’;õužIęŸÅ?‰ż¤“”GJ2ƒ’ óÅūƒŅāN}7øüÓ’n쓤%wźėüۘ’8(žmŲo“6wźėüĢ?éńO`?!m葒ȱ_Įü=žŲƐ6wź«ļźG«“ļžn—Ćvuƒ²ĖĮ¾#mādŲå°]mž]öiŁ4©'»¶+įŁå`ߑ¶õHq2ģrŲ® Ļ.ūŽ“l¢¾²+®åZŠŚ6±ÆÆ»~9ŚAłę~p1s¶ŹOŃł‰tUŚq½}ė—‹§IG1Æ®ėä~.ż9CĪŠ3ōĒ }æ”ļ7ō­†¾ÕŠśBCɰļdźĒ żø”?hčś †~ƒ”w ½cųE_ßŖH궒žvŽõ?cčĻzZ+]ß*2õ§ ż)CO|nūšūæā"zqT›ŻŽP~B€÷ĄĶ#zż1[ nę½ü!Ź»xā~žÉū]H-čĄ+:”Ž8l4ötÓ|NTC«k»¬Ķā0wÖɶ.+éG…Ļ`ŹY‘Ū}(pQš0ü§t±’ÕcÄU£ć”óĀq;^¼åm” īäßåFQž4|ØtA>lĮ¬††Š‡yāų#^ÜĄ÷«“…Æ`§…ļgĻ>Tŗ 6Ė8l }˜Ē\ZĄ¹t¹e.-ā\ŗŌ'—Yų°’Ŗqś0?÷£¼āēg>¤Zč#®…N>Tŗ &ń/ŒĆüq¤ü7Ä{…1‹šō*v†¹} 2}ØtA5i#z0ś//©i·>I[ųļ5ŗßŃŽ‚ī…†’”.ōß½­ežå½ū°«eŚ9^» »–i‡ąZ'=ŲęŠ<ĘąćƒM–1XĪ1Xėƒå1Ų ļ‚”’ņU‹ī·}ģjŃ]üūāČ®EwĶ¾¾=ŲĘ`kѳąÖ¢—Į®=n-z ²kŃó>l”æ®Õ‡>ĢĒ›üģķåž±Č£ń\\é>Tŗ <Ś,=ś/_1ų4Ē`§e Öq ¦|b°ĪŖ–I†{ś<ļr}¹Ör?ø˜÷ƒ•>ūĮÅžā^r¤’™Ņśīó¢AžŪ-ÜēWßą’ÉėžSŗ ’Õ¢’`’Ķ.¹üŌĶyõžXG˜ĘogJÉį§.é§Jé›Ķ’ō,Įć~gą*]püÖŹuP9ŲÄ?ŹųūąµĄÆĄļeü!ü^ üd~ć§|šė„Ķ^-7¾`üR|!l~É\ü+Į"¾›šO0ž>ų'¬j°Üų{’°ž^ ü–üĘɿÿuü>~?`!ć—ųJ³ˆ/»śa.½ó\śŹ6ĀÅqŸ’>’é„+Éį“>ł|ŲŲ»”𯆔ń\”że‰óū!ÅŚż1Ŗłq3?ēqē}XdsRŗł98Ń;ķšŖä±e«ėBcĪyüÓꦷ^.ž»>s+]$æūä{'Å><¢>ķ¹Ē1 'n#v#vd#vā#v>:V ” t ö6ö,Ö5Ö9Ö/Ö ’/Ö  ’/Ö ’’’’’’ą’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ(’’’’’’’’ż$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V ”’ t ö6ö,Ö 5Ö 9Ö /Ö ’/Ö  ’’’’’’ą’/Ö ’’’’’’ą’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö 4Ö pÖZ’’’’’’’’’’’’’’’’’’¤kdā]$$If”’ÖŹ ļ’o÷„ õ([=ø{"€"’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö 4ÖaöpÖZ’’’’’’’’’’’’’’’’’’Ż$$If–ļ’!vh5Ö5Ö„#v#v„:V ”’ t ö6ö,Ö5Ö9Ö/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö  ’2Ö 2Ö2Ö 2Ö4Ö pÖ’’’’Z$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’’’’’’ą’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö 4Ö pÖZ’’’’’’’’’’’’’’’’’’§kdfc$$If4”’ÖŹ ļ’o÷„ õ([=ø{"ą"’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ą"’’’’ą’’’’ą’’’’ t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö 4ÖaöpÖZ’’’’’’’’’’’’’’’’’’ų$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’Skdkh$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’ų$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’Skdŗl$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’ų$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’Skd q$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’Ü$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö  ’/Ö ’/Ö ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’SkdXu$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’Ż$$If–ļ’!vh5Ö5Ö„#v#v„:V ”’ t ö6ö,Ö5Ö9Ö/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö  ’2Ö 2Ö2Ö 2Ö4Ö pÖ’’’’Z$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’’’’’’ą’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö 4Ö pÖZ’’’’’’’’’’’’’’’’’’§kdjz$$If4”’ÖŹ ļ’o÷„ õ([=ø{"ą"’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ą"’’’’ą’’’’ą’’’’ t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö 4ÖaöpÖZ’’’’’’’’’’’’’’’’’’ų$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’Skdo$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’ų$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’Skd¾ƒ$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’ų$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’Skd ˆ$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’Ü$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö  ’/Ö ’/Ö ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’Skd\Œ$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’Ż$$If–ļ’!vh5Ö5Ö„#v#v„:V ”’ t ö6ö,Ö5Ö9Ö/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö  ’2Ö 2Ö2Ö 2Ö4Ö pÖ’’’’Z$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’’’’’’ą’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö 4Ö pÖZ’’’’’’’’’’’’’’’’’’§kdn‘$$If4”’ÖŹ ļ’o÷„ õ([=ø{"ą"’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ą"’’’’ą’’’’ą’’’’ t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö 4ÖaöpÖZ’’’’’’’’’’’’’’’’’’ų$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’Skds–$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’ų$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’Skdš$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’ų$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’SkdŸ$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’Ü$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö  ’/Ö ’/Ö ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’Skd`£$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’Ż$$If–ļ’!vh5Ö5Ö„#v#v„:V ”’ t ö6ö,Ö5Ö9Ö/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö  ’2Ö 2Ö2Ö 2Ö4Ö pÖ’’’’Z$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’’’’’’ą’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö 4Ö pÖZ’’’’’’’’’’’’’’’’’’§kdrØ$$If4”’ÖŹ ļ’o÷„ õ([=ø{"ą"’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ą"’’’’ą’’’’ą’’’’ t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö 4ÖaöpÖZ’’’’’’’’’’’’’’’’’’ų$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’Skdw­$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’ų$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’Skdʱ$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’ų$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’Skd¶$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’Ü$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö  ’/Ö ’/Ö ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’Skddŗ$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’Ż$$If–ļ’!vh5Ö5Ö„#v#v„:V ”’ t ö6ö,Ö5Ö9Ö/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö  ’2Ö 2Ö2Ö 2Ö4Ö pÖ’’’’Z$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’’’’’’ą’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö 4Ö pÖZ’’’’’’’’’’’’’’’’’’§kdvæ$$If4”’ÖŹ ļ’o÷„ õ([=ø{"ą"’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ą"’’’’ą’’’’ą’’’’ t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö 4ÖaöpÖZ’’’’’’’’’’’’’’’’’’ų$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’Skd{Ä$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’ų$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’SkdŹČ$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’‚ƒ„…†‡ˆ‰Š‹ŒŽ‘’“”•–—˜™š›œžŸ ”¢£¤„¦§Ø©Ŗ«¬­®Æ°±²³“µ¶·ø¹ž’’’ž’’’¼ž’’’¾æĄĮĀĆŠÅĘĒČÉŹĖĢĶĪϽž’’’ŅÓŌÕż’’’ŲŁŚŪÜŻŽßąįāćäåęēčéźėģķīļšńņóōõö÷ųłśūüżž’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’ų$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö ’/Ö ’/Ö ’/Ö  ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’SkdĶ$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’Ü$$If–ļ’!v h5Ö€5Öˆ5Ö®5ÖP5Ö35Ö35Öā5Ö{5Ö Ć#v€#vˆ#v®#vP#v3#vā#v{#v Ć:V 4”’ t ö6ö+Ö+Ö+Ö+Ö,Ö 5Ö 9Ö/Ö ’/Ö ’’’’’’ą’/Ö ’’’’’’ą’/Ö  ’/Ö ’/Ö ’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4Ö pÖ<’’’’’’’’’’’’SkdhŃ$$If4”’ÖŹ ļ’o÷„ õ([=ø{" "€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’€"’’’’’’’’ ’’’’ ’’’’  t ö6ööÖ$’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’’’’’’’’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö2Ö 2Ö4ÖaöpÖ<’’’’’’’’’’’’$$If–!vh5Öw 5ÖU 5Öo5Ö #vw #vU #vo#v :V –l4”“ t Ö0’’’’’’öˆ6ö+Ö,Ö5Ö5֏5ÖŁ5Ö9Ö9ÖpÖ(’’’’’’’’u$$If–!v h5Öw 5Ö5Ö5Ö5Ö5ÖI5Öo5Ör5Ö œ#vw #v#vI#vo#vr#v œ:V –l4”u t Ö0’’’’’’öˆ6ö+Ö,Ö 5Ö5Ö5Ö;5ÖŁ5ÖŒ5Ö {9Ö pÖZ’’’’’’’’’’’’’’’’’’`kd¢Ö$$If–l4Ö”uÖŹ ”’   `ĻAŻ# €€€€€;€Ł€Œ€${ t Ö0’’’’’’öˆ6ööÖ$’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’Ö$’’’’’’’’’4Ö4Ö laöpÖZ’’’’’’’’’’’’’’’’’’¤$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”; t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖd’’’’’’’’’’’’’’’’’’’’kd{Ś$$If–l4Ö”;Öą ”’3   `ĻAŻ#ą‘€ˆ€€€€€;ąŁą$Œą{ t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖd’’’’’’’’’’’’’’’’’’’’š$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”; t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’†kd³Ž$$If–l4Ö”;Öą ”’3   `ĻAŻ# ‘€ˆ€€€€€; Ł $Œ { t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’¤$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”Åž t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖd’’’’’’’’’’’’’’’’’’’’kd×ā$$If–l4Ö”ÅžÖą ”’3   `ĻAŻ#ą‘€ˆ€€€€€;ąŁą$Œą{ t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖd’’’’’’’’’’’’’’’’’’’’š$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”Åž t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’†kdē$$If–l4Ö”ÅžÖą ”’3   `ĻAŻ# ‘€ˆ€€€€€; Ł $Œ { t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’¤$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”Åž t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖd’’’’’’’’’’’’’’’’’’’’kd3ė$$If–l4Ö”ÅžÖą ”’3   `ĻAŻ#ą‘€ˆ€€€€€;ąŁą$Œą{ t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖd’’’’’’’’’’’’’’’’’’’’š$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”; t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’†kdkļ$$If–l4Ö”;Öą ”’3   `ĻAŻ# ‘€ˆ€€€€€; Ł $Œ { t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’¤$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”Åž t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖd’’’’’’’’’’’’’’’’’’’’kdó$$If–l4Ö”ÅžÖą ”’3   `ĻAŻ#ą‘€ˆ€€€€€;ąŁą$Œą{ t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖd’’’’’’’’’’’’’’’’’’’’š$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”; t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’†kdĒ÷$$If–l4Ö”;Öą ”’3   `ĻAŻ# ‘€ˆ€€€€€; Ł $Œ { t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’¤$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”Åž t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖd’’’’’’’’’’’’’’’’’’’’kdėū$$If–l4Ö”ÅžÖą ”’3   `ĻAŻ#ą‘€ˆ€€€€€;ąŁą$Œą{ t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖd’’’’’’’’’’’’’’’’’’’’š$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”; t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’†kd#$$If–l4Ö”;Öą ”’3   `ĻAŻ# ‘€ˆ€€€€€; Ł $Œ { t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’¤$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”Åž t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖd’’’’’’’’’’’’’’’’’’’’kdG$$If–l4Ö”ÅžÖą ”’3   `ĻAŻ#ą‘€ˆ€€€€€;ąŁą$Œą{ t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖd’’’’’’’’’’’’’’’’’’’’š$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”; t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’†kd$$If–l4Ö”;Öą ”’3   `ĻAŻ# ‘€ˆ€€€€€; Ł $Œ { t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’¤$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”Åž t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖd’’’’’’’’’’’’’’’’’’’’kd£ $$If–l4Ö”ÅžÖą ”’3   `ĻAŻ#ą‘€ˆ€€€€€;ąŁą$Œą{ t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖd’’’’’’’’’’’’’’’’’’’’š$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”; t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’†kdŪ$$If–l4Ö”;Öą ”’3   `ĻAŻ# ‘€ˆ€€€€€; Ł $Œ { t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’¤$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”Åž t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖd’’’’’’’’’’’’’’’’’’’’kd’$$If–l4Ö”ÅžÖą ”’3   `ĻAŻ#ą‘€ˆ€€€€€;ąŁą$Œą{ t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖd’’’’’’’’’’’’’’’’’’’’š$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”; t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’†kd7$$If–l4Ö”;Öą ”’3   `ĻAŻ# ‘€ˆ€€€€€; Ł $Œ { t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’¤$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”Åž t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖd’’’’’’’’’’’’’’’’’’’’kd[$$If–l4Ö”ÅžÖą ”’3   `ĻAŻ#ą‘€ˆ€€€€€;ąŁą$Œą{ t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖd’’’’’’’’’’’’’’’’’’’’š$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”; t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’†kd“!$$If–l4Ö”;Öą ”’3   `ĻAŻ# ‘€ˆ€€€€€; Ł $Œ { t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’¤$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”Åž t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖd’’’’’’’’’’’’’’’’’’’’kd·%$$If–l4Ö”ÅžÖą ”’3   `ĻAŻ#ą‘€ˆ€€€€€;ąŁą$Œą{ t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖd’’’’’’’’’’’’’’’’’’’’š$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”; t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’†kdļ)$$If–l4Ö”;Öą ”’3   `ĻAŻ# ‘€ˆ€€€€€; Ł $Œ { t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’¤$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”Åž t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖd’’’’’’’’’’’’’’’’’’’’kd.$$If–l4Ö”ÅžÖą ”’3   `ĻAŻ#ą‘€ˆ€€€€€;ąŁą$Œą{ t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖd’’’’’’’’’’’’’’’’’’’’š$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”; t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’†kdK2$$If–l4Ö”;Öą ”’3   `ĻAŻ# ‘€ˆ€€€€€; Ł $Œ { t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’¤$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”Åž t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖd’’’’’’’’’’’’’’’’’’’’kdo6$$If–l4Ö”ÅžÖą ”’3   `ĻAŻ#ą‘€ˆ€€€€€;ąŁą$Œą{ t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖd’’’’’’’’’’’’’’’’’’’’š$$If–!v h5ÖŸ5ÖŲ5Ö5Ö5Ö5Ö5ÖI5Öo5Ö r5Ö œ#vŸ#vŲ#v#vI#vo#v r#v œ:V –l4”; t Ö0’’’’’’öˆ6ö+Ö+Ö+Ö+Ö ,Ö 5Ö‘5Öˆ5Ö5Ö;5ÖŁ5Ö Œ5Ö {9Ö pÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’†kd§:$$If–l4Ö”;Öą ”’3   `ĻAŻ# ‘€ˆ€€€€€; Ł $Œ { t Ö0’’’’’’öˆ6ööÖ(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’Ö(’’’’’’’’’’4Ö4Ö laöpÖZ’’’’’’’’’’’’’’’’’’’’’’’’’’'$$If–!vh5Öw 5Ö5Ö5Ö5Ö5ÖI5Ö}#vw #v#vI#v}:V –l”Åž t Ö0’’’’’’öˆ6ö,Ö5Ö5Ö5Ö;5ÖąpÖF’’’’’’’’’’’’’’żkdĖ>$$If–l֔Ş֞”’   `Ż#€€€€€€;€ą t Ö0’’’’’’öˆ6ööÖ’’’’’’’Ö’’’’’’’Ö’’’’’’’Ö’’’’’’’4Ö4Ö laöpÖF’’’’’’’’’’’’’’SummaryInformation(’’’’HDocumentSummaryInformation8’’’’’’’’’’’’ÄØ&CompObj’’’’’’’’’’’’q’’’’’’’’’’’’ž’ą…ŸņłOh«‘+'³Ł0˜LXht„ œØ Č Ō ą ģųā¬Analysis of Helicobacter pylori serum antibody virulence protein profile in patients with benign and malignant gastroduodenal diseases and different patterns of gastritisTajanaNormalTRASPLATACIJA8Microsoft Office Word@Ō­ō@Ŗ²ÓĶ®É@Ņģ·×øÉ@¦š¬ŁøÉ+ƒž’ ’’’’ ĄFMicrosoft Office Word Document MSWordDocWord.Document.8ō9²q  Ćhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Tentor%20D%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlustUšhttp://www.ncbi.nlm.nih.gov/pubmed/15495287?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum*1javascript:AL_get(this, 'jour', 'Lijec Vjesn.');\7Éhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Kaleni%C4%87%20S%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlusUt Ähttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Dominis%20M%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus2  Āhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Turek%20S%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus)Āhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Babus%20V%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus%Åhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Presecki%20V%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus|KĆhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Strnad%20M%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstraž’ÕĶ՜.“—+,ł®DÕĶ՜.“—+,ł®Ų” hp|„Œ” œ¤¬“ ¼ sāNߙę «Analysis of Helicobacter pylori serum antibody virulence protein profile in patients with benign and malignant gastroduodenal diseases and different patterns of gastritis TitleŠ$ PD$L$X$”$¬$Ä$ _PID_HLINKS_AdHocReviewCycleID_NewReviewCycle_EmailSubject _AuthorEmail_AuthorEmailDisplayName_ReviewingToolsShownOnceāA,#6ME+javascript:AL_get(this, 'jour', 'APMIS.'); ,BĮhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Uibo%20R%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlusCj?Åhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Maaroos%20HI%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus0<Ęhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Vorobjova%20T%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus<G9;javascript:AL_get(this, 'jour', 'Scand J Gastroenterol.');x66Æhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Kuipers%20EJ%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlusm?3Æhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Kusters%20JG%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlusX0²http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Werdmuller%20BF%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlusp$-Æhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Loffeld%20RJ%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlust*}http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Correa+P%22%5BAuthor%5D*_'http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Yardley+JH%22%5BAuthor%5D^1$}http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Genta+RM%22%5BAuthor%5DB4!}http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Dixon+MF%22%5BAuthor%5D:Įhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Dhom%20G%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlusEpÄhttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Ziegler%20H%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlusi_ctPlus)™ž4[Fwd: RE: Rad 1752 ponovno za prihvatiti za Dvojku]mgaspic@mef.hrMarko Gaspic€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€IČ00 Iˆ00ŸIČ00€Iˆ00ŸIČ00€Iˆ00ŸIČ00€Iˆ00Ÿ˜@0€€˜@0€€IČ00 Iˆ00”Ÿ      Ń !"#$%&'()*+,-./0123456789:ž’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’†5œ   @@ń’@ >:NormalCJ_HaJmH sH tH Z@Z >: Heading 1$¤š¤<@&5CJ KH OJQJ\^JaJ \@\ >: Heading 2$¤š¤<@& 56CJOJQJ\]^JaJDA@ņ’”D Default Paragraph FontRi@ó’³R  Table Normalö4Ö l4Öaö (kō’Į(No List XžO¢ńX  Char Char9*5CJ KH OJQJ\^JaJ mH sH tH Zž¢Z  Char Char8,56CJOJQJ\]^JaJmH sH tH JB@J >: Body TextCJOJQJ^JaJmHsHFž¢!F  Char Char7CJ^JaJmH sH tH B*¢1B >:Endnote ReferenceH*^Jv+@Bv MY« Endnote Text/$ & F Ęh„„„„˜ždą^„„`„˜ža$OJQJ^JmHsHFž¢QF  Char Char6CJ^JaJmH sH tH F'¢aF >:Comment Reference CJ^JaJ<r< >: Comment TextCJaJFž¢F  Char Char5CJ^JaJmH sH tH @jqr@ >:Comment Subject5\4ž‚”4  Char Char45\H™²H >: Balloon TextCJOJQJ^JaJBž¢ĮB  Char Char3CJ^JmH sH tH 4 @Ņ4 >:Footer  ĘąĄ!Fž¢įF  Char Char2CJ^JaJmH sH tH 2)@¢ń2 >: Page Number^J:U@¢: >: Hyperlink>*B*^Jph3Ģ2X@¢2 >:Emphasis 6]^J2žO¢!2 >: ref-journal^J2žO¢12 >:ref-vol1 5\^J*žO¢A* >:ti2 CJ^JaJRRR &>: Footnote Text%CJOJQJ^JaJmHsHFž¢aF % Char Char1CJ^JaJmH sH tH D&¢qD >:Footnote ReferenceH*^J2žO‚2 >:text(¤d¤d[$\$lžO’l >:xl33I)$¤d¤d%d&d'dOĘ’PĘ’QĘ’[$\$a$@"@@ >:Caption*dh¤x¤xmHsH4@²4 ,>:Header + ĘąĄ!Dž¢ĮD + Char CharCJ^JaJmH sH tH 4/@Ņ4 >:List-„„åž^„`„åž"žO¢į" >:pub^J žO¢ń >:ti^J2žO¢2 Įq journalname^Jzš³z Ż Table Grid7:V1Ö0’’’’’’1_HmHsHtHRžO"R A)‘authors12„™dš¤H^„™CJaJmHsHtH2(@¢12 (ķ Line Number^JDžń’BDEmRevision4CJ_HaJmH sH tH Iš¼’’’’¢£¬ĆÕčł )*Ÿżkēčé=łd¼ ) * { ‰ ²/ˆ‰Š’“œBŹvw!!!!7#½%¾%É%''‘'™'š'«' )>*’+>,?,,(0)0n03‚3ƒ3Ž3ī496Ī;ō?ā@EIįNŪPÜPŻPčP`Q+WqXÕX\ZÓ\]©^_B`#aüaucdódšeļf¶ghbi!jkškćl mēpoqor6stįtßxN|}Ė}Ü~ø`€ ‚ƒ­„Æ……†p‡õ‡’ˆˆ£ˆ¤ˆØˆ·ˆÄˆÅˆĢˆŅˆŻˆŽˆßˆēˆńˆņˆóˆōˆ‰‰‰$‰%‰8‰B‰C‰Y‰c‰d‰v‰€‰‰”‰Ŗ‰«‰¬‰­‰Ą‰É‰Ņ‰Ó‰ą‰ė‰ō‰õ‰Š ŠŠŠ(Š2Š=Š>ŠJŠUŠ_Š`ŠƒŠŽŠ˜Š™ŠŖŠ“ŠæŠĄŠÅŠĻŠŚŠŪŠłŠ‹‹‹‹%‹0‹1‹6‹@‹K‹L‹j‹u‹‹€‹…‹‹š‹›‹œ‹‹¶‹æ‹Č‹É‹Š‹Ż‹č‹š‹ń‹ņ‹ū‹ŒŒŒŒŒ$Œ/Œ0Œ1ŒGŒQŒ\Œ]ŒdŒqŒ|Œ„Œ…Œ†ŒŒšŒ¤Œ„Œ¦Œ®ŒøŒĆŒÄŒÅŒŪŒåŒšŒńŒ Ž,ŽHg2<GPdopqw€‰•”£„Ø±²³ø¹ÄĻÖŲŪßąįēķó‘‘‘‘‘ ‘‘‘‘‘‘‘‘‘‘ ‘%‘+‘,‘-‘.‘/‘0‘2‘4‘6‘;‘A‘B‘C‘D‘E‘F‘J‘M‘Q‘R‘S‘T‘U‘V‘W‘X‘v‘w‘„‘‹‘‘‘‘‘’‘“‘™‘Ÿ‘„‘³‘“‘µ‘·‘ŗ‘½‘Ñɑʑˑ̑͑ΑБӑܑ֑ā‘ć‘ä‘å‘ę‘ē‘é‘ė‘ī‘ō‘ś‘ū‘ü‘ż‘ž‘’‘’’ ’ ’ ’ ’’’’’/’0’=’D’F’H’J’K’L’R’X’^’l’m’n’p’s’v’|’‚’ƒ’„’…’†’‡’‰’Œ’’•’›’œ’’ž’Ÿ’ ’¢’„’Ø’®’“’µ’¶’·’ø’¹’½’Į’Ä’Å’Ę’Ē’Č’É’Ź’Ė’Š’Ń’Ž’å’ē’é’ė’ģ’ķ’ó’ł’’’ “““““““#“$“%“&“'“(“*“-“0“6“<“=“>“?“@“A“C“F“H“N“T“U“V“W“X“Y“]“a“d“e“f“g“h“i“j“k“x“y“‚“‰“‹“““‘“’“˜“ž“¤“²“³“““¶“¹“¼““ȓɓʓ˓͓̓ϓѓԓړį“ā“ć“ä“å“ę“蓟“ķ“ņ“ł“ś“ū“ü“ż“ž“”” ” ” ” ” ”””—”Ÿ”³”»”ٔڔ۔ݔߔį”ć”ę”č”ė”ō”ö”÷”ü”••• • ••••*•0•1•2•7•9•;•=•?•A•B•C•D•E•I•N•Q•T•W•Z•\•b•h•v•|•}•~•ƒ•…•ˆ•‹•Ž••‘•’•“•”•˜•• •£•¦•©•«•±•·•ŕ˕͕̕ҕՕؕەޕą•į•ā•ć•ä•č•ķ•š•ó•ö•ł•ū•––––––"–%–'–*–-–/–0–1–2–3–7–<–?–B–E–H–J–P–V–d–j–k–l–q–t–v–y–|–~––€––‚–†–‹–Ž–‘–”–—–™–Ÿ–„–³–¹–ŗ–»–Ą–Ć–Ę–É–Ģ–Ļ–Š–Ń–Ņ–Ó–×–Ü–ß–į–ä–ē–é–ļ–õ–— — — ——————— —!—"—#—'—,—/—2—5—7—9—?—E—S—Y—Z—[—`—c—f—i—l—n—o—p—q—r—v—{—~——„—‡—‰——•—£—©—Ŗ—«—°—³—¶—¹—¼—¾—æ—Ą—Į—Ā—Ę—Ė—Ī—Ń—Ō—×—Ł—ß—å—ó—ł—ś—ū—˜˜˜ ˜ ˜˜˜˜˜˜˜˜˜!˜$˜'˜)˜/˜5˜C˜I˜J˜K˜P˜S˜V˜Y˜\˜^˜_˜`˜a˜b˜f˜k˜n˜q˜t˜w˜y˜˜…˜“˜™˜š˜›˜ ˜£˜¦˜©˜¬˜®˜Æ˜°˜±˜²˜Ī˜Ń˜Ō˜×˜Ś˜Ż˜Ž˜ß˜D™[™r™ę™ł™ š-š/š0š2š3š5š6š8š9šEšFšGšJš˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜(0€€˜(0€€˜(0€€˜(0€€˜(0€€˜(0€€˜(0€€˜0€€˜(0€€˜(0€€˜(0€€˜(0€€˜(0€€˜0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0 €€˜ 0 €€˜ 0 €€˜ 0 €€˜ 0 €€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0€€˜ 0 €€˜ 0!€€˜ 0"€€˜ 0#€€˜ 0$€€˜ 0%€€˜ 0&€€˜ 0'€€˜ 0(€€˜ 0)€€˜ 0*€€˜ 0+€€˜ 0,€€˜ 0-€€˜ 0.€€˜0€€©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ™0€€Ō ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ™0€€Ō ˜0€€˜0€€˜0€€˜0€€˜0€€©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ™0€€Ō ©0€€Š ©0€€Š ™0€€Ō ©0€€Š©0€€Š©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō ©0€€Š ©0€€Š ™0€€Ō ©0€€Š©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō ©0€€Š ©0€€Š ™0€€Ō ©0€€Š©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō ©0€€Š ©0€€Š ™0€€Ō ©0€€Š©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō ©0€€Š ©0€€Š ™0€€Ō ©0€€Š©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō ˜0€€©0€€Š ©0€€Š ©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ©0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š©0€€Š ©0€€Š ™0€€Ō © 0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š © 0€€Š © 0€€Š © 0€€Š ™0€€Ō ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€€Š ©0€ ę c+]œÉ#b-é/t5$9Ŗ:2>µBźC™FIOŠQ{RøS{U¢VYƒ^[`Gbe]knCq“r uy\zĻ|€æ°„ʼn–Œ†ŽœŅ‘L“¦”–Æ–i—I˜!™xšy›žœ»œ÷œH‹ģHž²žŸmŸŠŸ/ ˜ ß <£Ü£RUVWYZ[\^_`acdefghijklmnopqstuvwxyz{|~€‚ƒ›§«¬­®²¹æĀĆĘČÉĢĪŠŅŌÖŲŚÜŻ{7+;\bį|ÄŻńó‘B‘c‘€‘Ŗ‘¬‘Ņ‘ō‘’=’_’˜’æ’Ś’“0“K““š“œ“Č“š“””1”]”„”𔮔Ŕń”o˜”˜Ū˜-™v™“™ś™/šmš“šŠš›T›x›³›ł›ŁœćœA’čEž„ž ŸfŸæŸ q Ž Ü£SX]br}„…†‡ˆ‰Š‹ŒŽ‘’“”•–—˜™šœžŸ ”¢£¤„¦Ø©ŖÆ°±³“µ¶·øŗ»¼½¾ĄĮÄÅĒŹĖĶĻŃÓÕףŪŚ£T`Q0R9RsNsUsYs_s€sƒsļsósōsśstt#t+t/t6t:tCt³tĮtĆtĘtžuØukvxv8wBwx x7x;x»xČx³y¼y”z›zp{t{ā{č{N||ę|ģ|}$}2}8}p}t}¬}°}±}·}Ö}Ū}ŗ~¾~æ~Å~å~(•¢ĄĀĻÓ`€h€l€s€w€~€¦€Ŗ€ė€ō€#%4:ÕŁŚßäė ‚T‚ī‚õ‚ū‚ƒƒ ƒƒƒƒ!ƒŗƒ¾ƒŹƒĶƒĪƒÓƒŪƒāƒęƒģƒśƒ„­„¾„„ńɄ҄քć„ē„ō„Œ…™…Æ…ž…†††”†ž†¤†«†8‡A‡’‡ˆōˆžˆŚ‰Ž‰ū‰’‰Š&ŠDŠHŠŸŠØŠ‹‹‹­‹<ŒFŒ]ŒcŒŠŒŚŒ/Ki€£°ŁŚ ޤޯŽŅŽÜŽīŽōŽ/=ĀĪPYÄĪ=’C’r“v“‚“ˆ“Ÿ”©”ń˜%™[™a™b™i™j™q™§™­™Ć™Ķ™Ļ™Ü™Ž™å™ę™ų™-š-š/š/š0š0š2š3š5š6š8š9šGšJš– « (˜(”))JQNQW"WaXdX±XŌXLZOZ\Z>\Ā\Å\€]‚]š^^}_€__É_3`;`aaėaļaccfc dddldądädŻeąeše;fÜfßf¤g§g€hƒh·høhUiXijjļjņjßkćkÓlÖlŌp×pēp q^qnqoqŗq[r^r$s'stt7t8tÕtŲtžuxĻxŅx>|B|N||ņ|ö|½}Ą}Ė~Ī~Ü~(Ø«P€S€›€¤€ś€ž€ńó‚T‚܂߂؃«ƒš„ž„Ÿ…¢…Æ…ž…r†v†`‡c‡ź‡ģ‡ö‡‘ˆņŒ Ž-Ž6Žhp””\•a•ߘ%™ę™ų™ šš-š-š/š/š0š0š2š3š5š6š8š9šGšJš333333333333333333333333333333333333333333333333333333ĆŌÕł ō 9 „CõCŻPčP,W4WPXqXEgŽgUqoq³xĖx|į|’ˆ$‰%‰B‰C‰c‰d‰€‰”‰ō‰õ‰ŠŠ=Š>Š_ŠƒŠ˜Š™ŠæŠĄŠŚŠŪŠ‹‹0‹1‹K‹L‹‹€‹š‹‹š‹ņ‹ŒŒ/Œ1Œ\Œ]Œ„Œ†Œ¤Œ¦ŒĆŒÅŒšŒ2cdnq§Ø·¹ßįņó‘‘.‘0‘D‘F‘Q‘X‘v‘w‘‘‘“‘¤‘„‘̑Αå‘ē‘ż‘’‘ ’’/’0’J’L’]’^’…’‡’ž’ ’·’¹’Ä’Ė’Ļ’Ń’ė’ķ’ž’’’&“(“?“A“W“Y“d“k“x“y““’“£“¤“˓͓ä“ę“ü“ž“ ”—”³”µ”ź”ė”ö”÷”••0•2•B•E•|•~•‘•”•¶•·•˕͕į•ä•––––0–3–U–V–j–l––‚–¤–„–¹–»–Š–Ó–ō–õ– — — —#—D—E—Y—[—o—r—”—•—©—«—æ—Ā—ä—å—ł—ū—˜˜4˜5˜I˜K˜_˜b˜„˜…˜™˜›˜Æ˜²˜Ż˜ß˜ī˜[™r™-š-š/š/š0š0š2š3š5š6š8š9šGšJš-š-š/š/š0š0š2š3š5š6š8š9šGšJš Iʊģ]’’’’’’’’FGŠY$7ŗ7’’’’’’’’’ķE—`Ģ‹ų„’’’’’’’’’9XĪ?įyĒå}I2Ä9čD°J Ō L$ ąy-g1@Įqė ,-ļ6:t$ąD3\Ūc“P š  “ y ČU :.ģ}Ÿ\µo F@9[ Ä*¾3JB:Iż!F—qK,EmÄ6!OlB’*×_”%ÉGšk0 °V† ŠJ!Ńw!·}!ƒ #£L#õU#FL$“+%č8%®h%Rt%%&—m&¶n&é)'ę*'ļ.(ĒP(Dr*W#,/,K-Žs-0E.:c/ 60OJ0ŌU0:1‚{1Ł2ŪF2Y]3Ä4Ā44 c4;M5®!6Ž)7ĒA9>:Ž|:Å.=Qh=äp==v=Č=>’~>G?L"?I9?ˆG?ŁN?Äx? @žn@sGBäOBnWCüXDÅmDŃyE}FVBFBTFX G.J­FJ4~J?DK€EKČLKž@LqjL$Mm1OĘNO `PkR×tRų|R÷SŽsSŚzSÆrTźU UmU‘pU V@WĮ X6.X“Z#2Z+rZ;[¦\IH\!]Ūz]Ė^Źe^ė<_0.`ü0`¢Z`‚9a·Eaœpa÷bFHcŖgcJ4fK?f8]f³rfS4i{jBjßTk ll(m6`oŌioĻq,ru s“)u¼0wą0wuwgxV?xī3y³hyiy‚&{ue{×~|­I}śN} ~I~”ķźKvQ7€.€ŠS€‡m€4ųEb-‚Ūƒ5,ƒj!„>„t&…©I…)3†łg†_‡t4‡ūC‡ŚW‡Goˆ“ˆ,.‰S‰Qj‰¶u‰BŠ+Š\7Š#}Š[‹XE‹ŒgŒHdŒ¬yŒˆ"ĀjógphpA)‘n‘P"“c• •Õ˜8šł›‘›{ ›ń$›L›„t›ma6žaž¶)Ÿk;ŸyDŸh[ n\ ¢KZ¢{`¢y¤:¤āA¤;$„‹B„Än§ŚMØ?|Ø(6©Æs©wŖi_ŖĻ~Ŗ $«MY«€j«Ü¬Ö­ės­©y­7®¹S®mj®ńl®1 Æ2 °.°qm±łb²īp²t² “S “o#“ŗ<“¶µRUµ|%¶æ(¶ćT¶øU¶Äb¶tq¶EWøĄgøŪk¹źx¹Wŗ+»£T»^m¼Żz¼ō ¾wE¾ŲN¾¾Kæ6Mæķhæ“oæį~ĄBnĮ«sĮāĀ«ÄŌPÄ6WÄO ÅÅSÅZÅs)ĘĀsĘ MĒō-Ȏ>Č ɜÉåMÉhOÉKqÉoŹq'ŹāCŹÆKʘuŹŚĖ@)ĖpĖkĢ0ĪR?ĪcxĻŠŁQŠ&cŠØ(ŃlыbŅņoŅøŌ–2ŌG9Ō8ÕtjÖÆz×6ŲQ!Ł‘@Ł7fŁÉŚfŚ@lŚū@Ü ŻŻęBݜŽ=ąņ#ą€hąt į4įæBįjHįadį»āc7ā{gāZ*ä±/äEä eå#ęy,č)Hč éIźō%ė¾ģ+)ģ0-ģ(ķmī9|īUļ!0ļóOļ9|ļuDń{bńr:ó+<óÉIõ³öć3öØ5ö¶Aö÷Ō÷8÷¬f÷Ü2ų—ł[4ł zł¬śšMś}ü‡-üķHü¦żŅKżvOż’sżF’ć’b|’;p‡õ‡’ˆˆ£ˆ¤ˆØˆ·ˆÄˆÅˆĢˆŅˆŻˆŽˆßˆēˆńˆņˆóˆōˆ‰‰‰$‰%‰8‰B‰C‰Y‰c‰d‰v‰€‰‰”‰Ŗ‰«‰¬‰­‰Ą‰É‰Ņ‰Ó‰ą‰ė‰ō‰õ‰Š ŠŠŠ(Š2Š=Š>ŠJŠUŠ_Š`ŠƒŠŽŠ˜Š™ŠŖŠ“ŠæŠĄŠÅŠĻŠŚŠŪŠłŠ‹‹‹‹%‹0‹1‹6‹@‹K‹L‹j‹u‹‹€‹…‹‹š‹›‹œ‹‹¶‹æ‹Č‹É‹Š‹Ż‹č‹š‹ń‹ņ‹ū‹ŒŒŒŒŒ$Œ/Œ0Œ1ŒGŒQŒ\Œ]ŒdŒqŒ|Œ„Œ…Œ†ŒŒšŒ¤Œ„Œ¦Œ®ŒøŒĆŒÄŒÅŒŪŒåŒšŒńŒg2<GPopqw€‰•”£„±²³ø¹ÖŲŪßąįēķ‘‘‘‘‘ ‘‘‘‘‘‘‘‘‘‘ ‘%‘+‘,‘-‘.‘/‘0‘2‘4‘6‘;‘A‘B‘C‘D‘E‘F‘J‘M‘Q‘R‘S‘T‘U‘V‘W‘X‘v‘w‘‹‘‘‘‘‘’‘“‘™‘Ÿ‘³‘“‘µ‘·‘ŗ‘½‘Ñɑʑˑ̑͑ΑБӑܑ֑ā‘ć‘ä‘å‘ę‘ē‘é‘ė‘ī‘ō‘ś‘ū‘ü‘ż‘ž‘’‘’’ ’ ’ ’ ’’’’’/’0’D’F’H’J’K’L’R’X’l’m’n’p’s’v’|’‚’ƒ’„’…’†’‡’‰’Œ’’•’›’œ’’ž’Ÿ’ ’¢’„’Ø’®’“’µ’¶’·’ø’¹’½’Į’Ä’Å’Ę’Ē’Č’É’Ź’Ė’Š’Ń’å’ē’é’ė’ģ’ķ’ó’ł’ “““““““#“$“%“&“'“(“*“-“0“6“<“=“>“?“@“A“C“F“H“N“T“U“V“W“X“Y“]“a“d“e“f“g“h“i“j“k“x“y“‰“‹“““‘“’“˜“ž“²“³“““¶“¹“¼““ȓɓʓ˓͓̓ϓѓԓړį“ā“ć“ä“å“ę“蓟“ķ“ņ“ł“ś“ū“ü“ż“ž“”” ” ” ” ” ”””—”Ÿ”³”»”ٔڔ۔ݔߔį”ć”ę”č”ō”ö”÷”ü”••• • •••*•0•1•2•7•9•;•=•?•A•B•C•D•E•I•N•Q•T•W•Z•\•b•v•|•}•~•ƒ•…•ˆ•‹•Ž••‘•’•“•”•˜•• •£•¦•©•«•±•ŕ˕͕̕ҕՕؕەޕą•į•ā•ć•ä•č•ķ•š•ó•ö•ł•ū•–––––"–%–'–*–-–/–0–1–2–3–7–<–?–B–E–H–J–P–d–j–k–l–q–t–v–y–|–~––€––‚–†–‹–Ž–‘–”–—–™–Ÿ–³–¹–ŗ–»–Ą–Ć–Ę–É–Ģ–Ļ–Š–Ń–Ņ–Ó–×–Ü–ß–į–ä–ē–é–ļ–— — — ——————— —!—"—#—'—,—/—2—5—7—9—?—S—Y—Z—[—`—c—f—i—l—n—o—p—q—r—v—{—~——„—‡—‰——£—©—Ŗ—«—°—³—¶—¹—¼—¾—æ—Ą—Į—Ā—Ę—Ė—Ī—Ń—Ō—×—Ł—ß—ó—ł—ś—ū—˜˜˜ ˜ ˜˜˜˜˜˜˜˜˜!˜$˜'˜)˜/˜C˜I˜J˜K˜P˜S˜V˜Y˜\˜^˜_˜`˜a˜b˜f˜k˜n˜q˜t˜w˜y˜˜“˜™˜š˜›˜ ˜£˜¦˜©˜¬˜®˜Æ˜°˜±˜²˜Ī˜Ń˜Ō˜×˜Ś˜Ż˜Ž˜ß˜ šJš<žžžžžžžžžžžžžžžžžžžžžžžžžžžžžžžžžž–3žžžžžžžžžžžžžžžžžžžžžžžžžžžžžžž–žžžžžžžžžžžžžžžžžžžžžžžžžž–’@€øNøN¬'4øNøN[™Iš€@€¢’’Unknown’’’’’’’’’’’’ Gī‡z €’Times New Roman5€Symbol3&ī ‡z €’Arial7&ī ‡ ŸVerdanaU.īļ { @ŸCalibriCentury Gothic7īļ K@ŸCambria5&ī ‡za€’Tahoma?5ī ‡z €’Courier New;€Wingdings"ˆšŠ©÷IŌ† JŌ†SŪÓ¦+ƒN+ƒNš‰‰x“‚4ߙߙ2ƒQšüżHš’$P’’’’’’’’’’’’’’’’’’’’’—ł2’’ŖAnalysis of Helicobacter pylori serum antibody virulence protein profile in patients with benign and malignant gastroduodenal diseases and different patterns of gastritisTajana TRASPLATACIJA